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ABSTRACT OF THE DISSERTATION
ADAPTIVE CLOSED-LOOP NEUROMORPHIC CONTROLLER FOR USE IN
RESPIRATORY PACING
by
Ricardo Siu
Florida International University, 2019
Miami, Florida
Professor Ranu Jung, Major Professor
Respiratory pacing can treat ventilatory insufficiency through electrical stimulation
of the respiratory muscles, or the respective innervating nerves, to induce
ventilation. It avoids some of the adverse effects associated with mechanical
ventilation such as risk of diaphragm atrophy and lung damage. However, current
respiratory pacing systems provide stimulation in an open-loop manner. This often
requires users to undergo frequent tuning sessions with trained clinicians if the
specified stimulation parameters are unable to induce sufficient ventilation in the
presence of time-varying changes in muscle properties, chest biomechanics, and
metabolic demand. Lack of adaptation to these changes may lead to complications
arising from hyperventilation or hypoventilation.
A novel adaptive closed-loop neuromorphic controller for respiratory pacing has
been developed to address the need for closed-loop control respiratory pacing
capable of responding to changes in metabolic production of CO2, diaphragm
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muscle health, and biomechanics. A 3-stage processes was utilized to develop the
controller. First, an adaptive controller that could follow a preset within-breath
volume profile was developed in silico and evaluated in vivo in anesthetized rats
with an intact spinal cord or with diaphragm hemiparesis induced by spinal cord
hemisection. Second, a neuromorphic computational model was developed to
generate a desired trajectory that reflects changes in breath volume and
respiratory rate in response to arterial CO2 levels. An enhanced controller capable
of generating and matching this model-based desired trajectory was evaluated in
silico and in vivo on rats with depressed ventilation and diaphragm hemiparesis.
Finally, the enhanced adaptive controller was modified for human-related
biomechanics and CO2 dynamics and evaluated in silico under changes of
metabolic demand, presence of muscle fatigue, and after randomization of model
parameters to reproduce expected between-subject differences. Results showed
that the adaptive controller could adapt and modulate stimulation parameters and
respiratory rate to follow a desired model-generated breath volume trajectory in
response to dynamic arterial CO2 levels. In silico studies aimed at assessing
potential for clinical translation showed that an enhanced controller modified for
human use could successfully control ventilation to achieve and maintain
normocapnic arterial CO2 levels. Overall, these results suggest that use of an
adaptive closed-loop controller could lead to improved ventilatory outcomes and
quality of life for users of adaptive respiratory pacing.
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CHAPTER 1
INTRODUCTION
The respiratory system carries out one of the main life-sustaining functions in the
human body. It allows for delivery of oxygen to tissues and removal of carbon
dioxide, a by-product of metabolic activity. Gas exchange between circulation and
the outside air is driven by ventilation, the process of cycling outside air to the
lungs. Yet, ventilatory insufficiency may occur due to traumatic, pharmacologic, or
pathogenic

factors

affecting

the

central

respiratory

center,

respiratory

motoneurons, or the respiratory muscles. Examples of these include brainstem
ischemia due to stroke, congenital central hypoventilation syndrome, and
respiratory muscle paralysis due to cervical spinal cord injury. A 2018 report on
spinal cord injury statistics in the United States listed that over 4,000 people
admitted for hospitalization due to spinal cord injury required ventilatory
assistance, with a quarter requiring ventilatory assistance after hospitalization
(National Spinal Cord Injury Statistical Center, 2018).
Often, ventilatory insufficiency is treated by mechanical ventilation. Mechanical
ventilation is efficient in carrying out gas exchange, however, there are significant
drawbacks with chronic use. The diaphragm muscle is passive during mechanical
ventilation which can lead to muscle atrophy after prolonged mechanical ventilator
use, delaying the time required for recovery and weaning from the ventilator when
recovery is possible (Goligher et al., 2015; Levine et al., 2008; Vassilakopoulos,
2012; Zambon et al., 2016). Mechanical ventilators are also often set to
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hyperventilate the patients (Slutsky, 1993). Hyperventilation, while acceptable, can
lead to lightheadedness and, in severe cases, loss of consciousness (Brown,
1953). Some ventilator modalities can also damage the alveoli by overinflating or
by delivering pressures higher than the alveoli can withstand (Ricard et al., 2003;
Vassilakopoulos, 2012). In addition, mechanical ventilators are often bulky and
require invasive tubing. This reduces the patient’s mobility, speech capabilities,
and as result, their quality of life.
An alternative to mechanical ventilation is respiratory pacing. Respiratory pacing
consists of implanting bilateral stimulating electrodes on either the phrenic nerve
or in the diaphragm muscle near the neuromuscular junction and then delivering a
current to elicit a diaphragmatic contraction to create a negative pressure and draw
air into the lungs. This approach mimics the intrinsic ventilatory biomechanics and
thus is less likely to cause exceedingly large pressures that might damage the
alveoli (DiMarco, 2005; Khong et al., 2010; Onders, 2012). Atrophy is also
ameliorated or avoided through this approach as the muscular contraction recruits
muscle fibers, effectively exercising the muscle (Ayas et al., 1999; Garara et al.,
2016; Pavlovic and Wendt, 2003; Reynolds et al., 2017).
The respiratory pacing systems currently in the market are open loop systems that
require manipulation by a clinician or technician to determine suitable stimulation
parameters. Not only does this increase the time required for setup, but the
stimulation patterns selected do not account for future changes in diaphragm
muscle recruitment requirements that might occur due to factors such as postural
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changes, onset of fatigue, and/or electrode encapsulation. Additionally, ventilatory
parameters also remain constant throughout normal use of the pacing system
unless a technician intervenes and adjusts these parameters. This may lead to
hypoventilation or hyperventilation as ventilatory demand can vary due to daily
activity, such as during sleep or periods of physical activity. This highlights the
need for a closed-loop controller capable of accounting for not only changes in
respiratory muscle activation requirements but also to changes in metabolic
demand if proper ventilatory function is to be achieved during chronic use of
respiratory pacing systems.
An adaptive closed-loop neuromorphic controller was developed for use in
respiratory pacing for treatment of hypoventilation. The design of the closed-loop
controller is based on the organizational structure of mammalian biological
ventilatory control, in which a central pattern generator determines ventilatory
behavior while the downstream neural connections and effector muscles
determine the resulting breath “shape”. This Pattern Generator (PG) Pattern
Shaper (PS) controller was developed and characterized in in silico rat and human
testbeds and in vivo on spinal cord intact and spinal cord injured rats. These
studies showed that the PG/PS controller could determine a proper ventilatory
response to changes in arterial CO2 reflected in end-tidal CO2 (etCO2) and adapt
stimulation amplitude and timing to match the proper ventilatory response
independent of presence of injury and body weight. The results obtained through
these studies suggest that use of this novel PG/PS respiratory pacing controller
could reduce the need for monitoring the user, increase the range of activities the
3

user can perform without falling into hypoventilation, and eliminate the need for
long and tedious stimulation tuning sessions.
1.1 Rationale
The work presented here describes the development of a novel closed-loop
adaptive controller capable of regulating ventilatory behavior by mimicking the
neurophysiological control of ventilation. Biological control of ventilation is a
dynamic process controlled by a complex neural network within the lower
brainstem that takes into consideration a multitude of factors of mechanical,
chemical, and neural origin to generate a corresponding ventilatory pattern (Botros
and Bruce, 1990; Molkov et al., 2017; Ogilvie et al., 1992; Smith et al., 1991, 2000,
2009). This central neural network controls activation of the respiratory muscles to
elicit a negative pressure in the thoracic cavity, drawing air into the lungs for gas
exchange to occur. The adaptive closed-loop controller presented in this work
mimics this biological architecture of ventilatory control by implementing a
computational model of the respiratory central pattern generator (rCPG) and a
model of chest biomechanics to generate a ventilatory pattern appropriate for the
current PaCO2 or etCO2 levels. A neural network with learning capabilities then
defines and adapts stimulation parameters to eliciting the desired response set by
the rCPG model.
Use of an adaptive closed-loop controller addresses the issues pertaining to openloop control respiratory pacing systems. By being able to dynamically modulate
ventilation, the adaptive PG/PS controller can respond to changes in metabolic
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production of CO2 that may result from change in activity levels. This expands the
range of activities the user can engage in without suffering from inadequate
ventilation, improving quality of life. Meanwhile, the adaptive PG/PS controller’s
ability to adapt stimulation parameters to match the desired ventilatory profile
allows for the controller to always elicit the adequate breath volume profile
independent of onset of fatigue, disease affecting ventilatory lung compliance or
resistance, postural effects, or changes in diaphragm muscle mass due to
stimulation-induced recovery from atrophy. These improvements over open-loop
respiratory pacing systems may eventually allow chronic use of respiratory pacing
technology that is analogous to biological ventilatory control, effectively restoring
lost or impaired ventilatory function.
1.2 Design Goals
The overall goal of the thesis presented in this document is the development,
characterization, and testing of a closed-loop adaptive respiratory pacing controller
able to adapt on a breath-by-breath basis to changes in metabolic rate, muscle
activation, and respiratory biomechanics. The adaptive closed-loop controller
should be able to autonomously:
-

Adapt stimulation parameters to elicit a desired breath volume profile
independent of the system’s intrinsic biomechanical properties.

-

Maintain the desired elicited breath volume profile regardless of changes in
muscle properties, such as fatigue.
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-

Determine an appropriate “desired” breath volume shape and duration
based on a measure of the patient’s arterial CO2 levels.

-

Update the desired breath volume and time profile in response to dynamic
changes in PaCO2 levels to achieve and maintain normocapnia.

The specific aims listed below serve to accomplish these goals and further
translation of the adaptive closed-loop controller for clinical use.
1.3 Specific Aims
1.3.1 Specific Aim 1
Specific Aim 1 is to develop a closed-loop adaptive respiratory pacing controller
capable of autonomously defining the stimulation waveform required to achieve a
previously defined breath volume at a fixed breathing frequency. This specific aim
can be subdivided into the following sub aims:
a) Development of a computational platform based on rat ventilatory
biomechanics in which the controller can be developed, optimized, and
assessed prior to in vivo implementation.
b) In vivo assessment in spinal cord intact rats to assess the controller’s ability
to match a desired ventilatory profile.
c) In vivo assessment in rats with spinal cord hemisection at the C2 level to
assess the controller’s ability to match a desired ventilatory profile in the
presence of diaphragm hemiparesis.
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1.3.2 Specific Aim 2
Specific Aim 2 is to include in the closed-loop adaptive controller the ability to
replicate the physiological ventilatory response to dynamic PaCO2 changes by
modulating breath volume and respiratory rate and to evoke this response through
adaptation of stimulation parameters. This is accomplished as per the following
sub aims:
a) Incorporation of an rCPG mathematical model into the closed-loop adaptive
controller to mimic the physiological ventilatory response and integration of
rat CO2 dynamics into the previously developed computational platform to
expand, optimize, and assess the controller’s ability to respond to dynamic
PaCO2 levels prior to in vivo implementation.
b) In vivo evaluation of the adaptive closed-loop controller’s ability to achieve
and maintain normocapnia in a rat model of central ventilatory deficiency
through anesthesia-induced ventilatory depression.
c) In vivo evaluation of the adaptive closed-loop controller’s ability to achieve
and maintain normocapnia after diaphragm hemiparesis in rats with spinal
cord injury through spinal cord hemisection at the C2 level.
1.3.3 Specific Aim 3
Specific Aim 3 is to modify the adaptive closed-loop controller to make it suitable
for human use in order to prepare the technology for human clinical trials. The
results obtained in this aim serve to narrow the bridge between the preclinical
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studies developed in Aims 1 and 2 and future clinical assessment of the PG/PS
controller. Specific Aim 3 is subdivided into the following sub aims:
a) Development of a computational testbed based on human ventilatory
biomechanics and CO2 dynamics and conversion of the closed-loop
adaptive controller to human use.
b) Computational assessment of the adaptive closed-loop controller’s
response to changes in CO2 production due to metabolic demand changes
in an integrated human computational testbed.
c) Computational assessment of the adaptive closed-loop controller’s
response to differences in muscle activation due to fatigue of the diaphragm
muscle in an integrated human computational testbed.
d) Computational assessment of the adaptive closed-loop controller’s ability to
adapt to variations in ventilatory biomechanics and CO 2 dynamics in an
integrated human computational testbed.
1.4 Organization of the dissertation
Chapter 1 serves as an introduction to the dissertation and discusses the rationale,
design goals, specific aims, and organization of the dissertation.
Chapter 2 consists of a review of the pertinent literature, computational model
selection, and rationale for the controller design.
Chapter 3 describes the design of the PS controller for diaphragmatic pacing and
its assessment in silico and in vivo.
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Chapter 4 presents the implementation of an adaptive PG into the PS controller
and its development and assessment in silico and in vivo.
Chapter 5 focuses on the translational aspect of the adaptive PG/PS controller and
its adaptation to a human implementation. It also presents a human computational
testbed capable of assessing temporally acute and chronic factors that are of
significance in a clinical setting.
Chapter 6 describes the significance of this thesis, its impact, limitations, and the
future work to be addressed prior and during clinical implementation.
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CHAPTER 2
LITERATURE REVIEW

2.1 The ventilatory control loop
Ventilation, when not under voluntary control, originates from complex neural
networks in the lower brainstem, is determined by input from physiological sensors
around the body, and is placed into action through respiratory muscle activity.
From an engineering standpoint, the ventilatory control loop can be simplified and
broken down into three main components: The effector muscles that activate to
initiate gas exchange, the sensors consisting of central and peripheral
chemoreceptors that detect changes in blood gas concentrations as a result of gas
exchange, and the controller which resides in the brainstem and dictates the
activity of the effectors based on input from the sensors. These three components
work together to form a closed-loop system capable of maintaining proper levels
of pH, pCO2, and pO2. An introduction to each of these components will follow in
this section
2.1.1 Biomechanical action of respiratory muscles
While gas exchange in the alveoli is a passive process, cycling the air in the alveoli
is not. The process through which air is cycled through the lungs is called
ventilation. Ventilation occurs as the inspiratory muscles contract, expanding the
thoracic cavity and thus creating negative pressure, drawing air into the lungs.
When required, expiratory muscles also play a role by reducing the thoracic
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volume and, through positive pressure, expel air out of the lungs. The muscles
driving inspiration can be classified into three main groups. A large diameter domelike internal muscle called the diaphragm located between the thoracic and
abdominal cavity which when contracted flattens and thus increasing thoracic
volume. Several smaller muscles within the rib’s interspace which elevate the ribs
and thus expand the thorax outwards called the external intercostal muscles. And
a variety of smaller muscles collectively known as accessory inspiratory muscles.
As for expiration, abdominal muscles serve to contract the abdominal wall,
increasing abdominal pressure and pushing the diaphragm muscle towards the
thorax while the internal intercostal muscles oppose the action of the external
intercostal muscles (De Troyer et al., 2005; Sauleda et al., 1998).
The main inspiratory muscle, the diaphragm, normally performs the majority of the
ventilatory work, contributing with up to 65% of the total inspiratory force (Jarosz
et al., 2012). However, synergistic activation of inspiratory muscles leads to an
effect greater than a simple additive contribution (De Troyer et al., 2005). The
prime example being diaphragm and external intercostal coactivation. Studies
have shown that activation of just the diaphragm can lead to a paradoxical
movement of the rib cage as it is drawn into the thorax by the negative pressure
exerted by the diaphragm. However, when coactivation between the diaphragm
and external intercostals occur, this inverse movement of the rib cage does not
occur and is instead moving in an outward motion, increasing thoracic space and
thus negative pressure (De Troyer and Estenne, 1984). This activation between
separate muscle groups also allows for other non-ventilatory behaviors such as
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sighing, coughing, and sneezing to occur. However, these are beyond the scope
of this thesis and will not be expanded up on.
Besides muscle activation patterns, there are several factors that influence how
respiratory muscle contractions affect the resulting breath volume. From a
mechanical perspective, these properties include chest compliance, airway
resistance, and inertance. Chest compliance refers to the distensibility of the lung
tissue. Stiff lung tissue, due to diseases such as fibrosis, lead to reduced
compliance and thus require more work from the respiratory muscle to evoke
adequate breath volumes (Nagels et al., 1980; Plantier et al., 2018). Likewise,
increased airway resistance will require more work to draw air into the lungs, such
is the case with asthma (Nagels et al., 1980). Inertance relates to the acceleration
of gas during respiration. Studies have shown that if high, as may occur in obesity,
elevated pulmonary pressures are required to evoke maximal ventilatory
maneuvers (Nagels et al., 1980; Sharp et al., 1964).These factors, along with the
force generated by the respiratory muscles, have an effect on the breath’s
volumetric profile.
2.1.2 Respiratory feedback sensors
As the respiratory muscles contract and drive gas exchange within the body,
changes in blood gas levels occur throughout the vasculature and are detected by
central and peripheral chemoreceptors. Peripheral chemoreceptors in the carotid
and aortic bodies respond to changes in arterial O2, and arterial CO2. Likewise,
central chemoreceptors located in the ventrolateral surface of the medulla
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oblongata respond mostly to changes in pH of the cerebrospinal fluid (Barnett et
al., 2017; MacLeod, 1925; Ursino and Magosso, 2002).
To prevent over-inflation of the lungs that might cause tissue damage, peripheral
mechanoreceptors called pulmonary stretch receptors (PSR) provide mechanical
feedback which serves as a crucial indicator for the termination of inspiration
(Burnet and Hilaire, 1999; Rybak et al., 1997). This reflex is referred to as the
Hering-Breuer reflex. PSRs also play a significant role in synchrony of the
respiratory drive to an external source. Several studies in animals and humans
have shown that removal of this feedback leads to an inability to synchronize
intrinsic ventilation to mechanical ventilation (Abu-Shaweesh et al., 1999; Harris
and St John, 2003; Simon et al., 2000).
For an extensive and comprehensive review of chemoreceptors and role in
regulation of breathing please see (Guyenet, 2014).
2.1.3 Respiratory central pattern generator
The respiratory central pattern generator (rCPG) integrates a variety of neural
inputs, including those from the chemoreceptors and mechanoreceptors discussed
in the previous section, to generate a ventilatory pattern capable of maintaining
adequate respiratory function. The rCPG has been shown to consist of several
neuronal populations distributed along the pons and medulla that mutually interact
to create a cyclical behavior from which respiratory rhythmogenesis arises (Kam
et al., 2013; Ogilvie et al., 1992; Smith et al., 1991, 2009). Activity from some of
these populations then travel through motor pathways to activate specific effector
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muscles at specific phases of the respiratory cycle, providing fine temporal tuning
of activation to elicit a specific ventilatory response.
Most respiratory rhythmogenesis models consist of a group of 5 or more mutually
interacting neuronal populations where each is more active than the others at
specific phases in the respiratory cycle. One of the earlier neural network models
based on the cat respiratory central pattern generator consisted of five neuronal
populations: pre-inspiratory, early-inspiratory, inspiratory, post-inspiratory, and
expiratory neurons (Botros and Bruce, 1990). This activity-based model showed
behavior that was comparable to that of experimental data and was able to predict
responses typical to hypercapnic behavior when chemoreceptor drive was
increased. The latest models have followed a similar trend and have been able to
replicate behaviors ranging from ventilatory response to hypoxia (Rubin et al.,
2011) to active expiration (Molkov et al., 2014a).
2.2 Impairments in respiratory control
The process of ventilation is dependent on a variety of components within the
respiratory system. These being the central controller found in the medulla, the
effector muscles that provide the mechanical action, and the chemoreceptors that
assess the level of CO2 or O2 found in the arterial bloodstream and feed into the
central controller. If any of these components or the links between them are
compromised, ventilatory activity will be depressed or cease completely, leading
to hypoventilation. Hypoventilation can lead to hypoxia, which can lead to cell
death in extreme cases, and to hypercapnia, which can cause cerebral damage,
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respiratory acidosis, and cardiac tissue damage. Hypoventilation can be the result
of a variety of conditions. Among them are spinal cord injury (Brown et al., 2006;
Linn et al., 2000; Zimmer et al., 2007), congenital central hypoventilation syndrome
(Berry-Kravis et al., 2006; Kasi et al., 2016), and Pompe disease (Fuller et al.,
2013; Smith et al., 2016).
Damage to the cervical region of the spinal cord above the level of C5, where the
phrenic motoneurons exit the spinal cord, might cause damage to the phrenic
motoneurons and descending respiratory pathways (Gonzalez-Bermejo et al.,
2015). Trauma at this level can lead to weakening or paralysis of the respiratory
muscles (Gardner et al., 1986; Linn et al., 2000). The 2018 National Spinal Cord
Injury Statistical Center report indicates that 19.9% of individuals with tetraplegia
in the USA are dependent on mechanical ventilation immediately after injury, with
roughly 30% of this population unable to produce sufficient tidal volume for
independent ventilation after rehabilitation (National Spinal Cord Injury Statistical
Center, 2018).
Congenital Central Hypoventilation syndrome (CCHS) is a rare congenital disorder
affecting the autonomic nervous system attributed to mutation of the PHOX2B
gene (Trang et al., 2005; Weese-Mayer et al., 2003, 2009). CCHS presents itself
with symptoms characteristic of autonomic nervous system dysregulation. These
include hypoventilation, which becomes more severe during sleep, sporadic
sweating, severe constipation, dysphagia, attenuated heart rate response to
exercise, and decreased basal body temperature (Weese-Mayer et al., 1999). To
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prevent hypoventilation, individuals with mild CCHS are often on assisted
nocturnal ventilation, with more severe cases being on continuous ventilatory
support (Berry-Kravis et al., 2006; Kasi et al., 2016).
Pompe disease is a muscular disease that results from lack of a glycogen
hydrolyzing enzyme, leading to accumulation of glycogen in many tissues but most
prominently muscle tissue leading to disfunction and, eventually, complete loss of
function (Fuller et al., 2013; Kishnani et al., 2006; Smith et al., 2016). Pompe
disease is characterized by rapid degradation of ventilatory function due
diaphragm dysfunction. While enzyme replacement therapy treatments are
available, these are unable to reach the central nervous system, which have been
shown to be affected by glycogen depositions and significantly affect ventilatory
function (Fuller et al., 2013).
2.3 Ventilatory support for ventilatory insufficiency
Hypoventilation, particularly chronic hypoventilation, can be a debilitating
condition.

Fortunately,

there

are

several

approaches for treatment

of

hypoventilation that have proven effective. These approaches differ in their
mechanism of action, target demographic, and overall effect on patient health.
2.3.1 Mechanical ventilation
Mechanical ventilation is the gold standard in the clinical setting when concerned
with ventilatory support. In the aforementioned cases, mechanical ventilators are
widely used to maintain proper ventilation. Mechanical ventilators function by
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creating a positive pressure that causes air to flow into the lungs. While mechanical
ventilators have a clear and effective role in intensive care units and in acute
respiratory assistance, chronic mechanical ventilator usage has considerable
drawbacks (Claxton et al., 1998; Ricard et al., 2003). Due to forceful inflation of the
lungs, alveolar damage might occur due to the high air pressures (Ricard et al.,
2003). Another major concern with chronic mechanical ventilation is respiratory
muscle atrophy (Andrew Shanely et al., 2002; Levine et al., 2008; Powers et al.,
2002; Zambon et al., 2016). This has severe implications if ventilatory rehabilitation
is expected. If the diaphragm muscle is weak, then weaning from a mechanical
ventilator becomes difficult and the time to recovery severely increases (Powers
et al., 2002). Other drawbacks of mechanical ventilators are the presence of
intrusive tubing that affects speech, the size of the device makes it harder to
transfer the patient, and there also exists a social stigma associated with
mechanical ventilators (DiMarco, 1999). These factors may lead to a significant
reduction in the quality of life of the ventilated individual.
2.3.2 Respiratory pacing
Respiratory pacing can serve as an alternative to mechanical ventilation. This
approach relies on functional electrical stimulation (FES) to cause a contraction of
the diaphragm muscle to create negative pressure within the thoracic cavity and
thus draw air into the lungs, effectively eliciting a breath (Chervin and
Guilleminault, 1994; DiMarco, 2009; Glenn et al., 1988; Onders, 2012). FES
triggers neural activity in the affected neural tissue by delivering pulse trains. Pulse
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trains are delivered to the phrenic nerve directly via a cuff electrode surrounding
the nerve itself, or indirectly via intramuscular stimulation through stimulating
electrodes in the proximity of the phrenic innervation site of the diaphragm.
FES used for artificial ventilation circumvents several of the problems found with
mechanical ventilators. Negative pressure produced by diaphragmatic contraction
reduces the likelihood of alveolar damage and atelectasis. Atrophy is also
ameliorated or avoided due to repetitive diaphragmatic contraction. Even in cases
where atrophy has already occurred, respiratory pacing was shown to have caused
some recovery in diaphragm muscle fiber size (Ayas et al., 1999). Given that air is
no longer being delivered to the patient through the mouth or trachea, tubing is no
longer a concern. This improves mobility of the user, speech, removes the stigma
associated with intubation, along with other benefits (Brown et al., 2006; DiMarco,
2009; Masmoudi et al., 2017; Onders, 2012; Onders et al., 2007).
2.3.3 Contraindications of respiratory pacing
While respiratory pacing has been shown to have a positive effect on respiratory
outcome in patients with spinal cord injury (DiMarco, 2005, 2018; Garara et al.,
2016; Glenn et al., 1984; Le Pimpec-Barthes et al., 2011; Onders, 2012), such has
not been the case in all clinical trials. Respiratory pacing is only possible when the
phrenic nerve is intact and the diaphragm is properly innervated for the neural
signals to be transmitted to the muscle fibers to cause a contraction (Chervin and
Guilleminault, 1994; Gonzalez-Bermejo et al., 2015; Jarosz et al., 2012; Lucangelo
et al., 2008). An example of respiratory pacing failing to improve respiratory
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outcomes was seen in a controversial study assessing effectiveness and safety of
pacing on patients with Amyotrophic Lateral Sclerosis (ALS) (Gonzalez-Bermejo
et al., 2016; McDermott et al., 2015). This study showed that, unlike during
mechanical ventilation, respiratory pacing was associated with decreased survival
in patients with ALS. The study raised the possibility of pacing induced
neuromuscular damage seen in animal models of ALS, which differs from healthy
models (Amirjani et al., 2012; Lepore et al., 2010). Additionally, given that ALS
causes degeneration of the neural and muscular tissue, electrical stimulation of
this damaged tissue likely adversely affects the behavior of the neuromuscular
system, either by decreased conductivity at the phrenic nerve level or reduced
contractile force capacity at the diaphragm level. Thus, selection criteria must be
clearly defined and followed prior to selection for respiratory pacing.
2.4 Stimulation approaches for respiratory pacing
Currently, three major approaches to respiratory pacing have been explored:
diaphragmatic stimulation, phrenic nerve stimulation, and spinal cord stimulation.
Each approach have their own benefits and drawbacks; however, increased,
however, increased performance comes with the cost of increased risk. Diaphragm
pacing poses a low surgical risk but requires multiple stimulating electrodes to elicit
the same response as observed in the other modalities. Phrenic nerve stimulation
introduces risk of phrenic nerve damage, which may permanently compromise
ventilatory function. However, if the stimulating electrodes are implanted properly,
widespread diaphragm contraction is likely to occur at a much lower charge than
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diaphragmatic stimulation (Onders, 2012). Finally, spinal cord stimulation poses
the greatest risk as damage to the spinal cord can affect function in several other
areas, however, by stimulating the premotor neurons, the muscle fibers are
recruited in a physiological manner, producing a more natural contraction.
Additionally, spinal cord stimulation of several muscles might lead to better
synergistic activation between the muscle sets, improve ventilatory capacity
(DiMarco et al., 2005, 2018).
2.5 Current respiratory pacing technology
Current phrenic pacing systems in the market are the Astrostim (Astrotech,
Tempere, Finland) and the Vienna phrenic pacemaker (Medimplant, Vienna,
Austria) in Europe and the Avery Breathing Pacemaker System (Avery Biomedical
Devices, NY, USA) (Khong et al., 2010), in the United States; these systems vary
mostly in their electrode technology (Onders, 2012). Only one system is available
commercially for diaphragmatic pacing, the NeuRx RA/4 System (Synapse
Biomedical, OH, USA). All four of these systems rely on an external stimulator on
which stimulation parameters are manually configured for open-loop stimulation.
The characteristic pulse amplitude, pulse width, and pulse frequency dictate the
level of muscular contraction in FES. These parameters along with cycle period
are often set by a technician or clinician to obtain a desired tidal volume and
respiratory rate. This implies that a technician/clinician must be consulted
whenever changes to these stimulation parameters are required. Aside from
adding to the cost of the treatment, this open-loop configuration does not account
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for changes such as changes in postural loading to the diaphragm, onset of pacinginduced muscle fatigue, and changes in electrode properties. Thus, a closed-loop
respiratory pacing controller that can account for these changes is desired.
2.6 Closed-loop FES control schemes
Despite clear limitations on open-loop strategies for control of FES of skeletal
muscle, lack of reliability, robustness, and sub-optimal performance have led to
limited availability of closed-loop FES control systems. Furthermore, most
proposed FES closed-loop control algorithms target control of limb movement
(Abbas and Chizeck, 1991; Cienfuegos et al., 2017; Davoodi and Andrews, 1998;
dos Santos et al., 2016; Feng Wang and Andrews, 1994; Ferrante et al., 2016;
Ferrarin et al., 2001; Freeman et al., 2009; Ibrahim et al., 2011; Kim et al., 2009;
Resquín et al., 2016; Wassink and Keller, 2004), with only a few studies
addressing closed-loop control of respiratory pacing (Mercier et al., 2017; Zbrzeski
et al., 2016). However, these closed-loop respiratory pacing approaches were still
in their infancy and required further investigation prior to clinical consideration.
Respiratory pacing poses additional demands on robustness and reliability of the
control algorithm as failure may lead to lung damage, severe hypoventilation, or
complete cessation of breathing. Traditional PID controllers may provide
acceptable tracking performance for short periods of time and are often resistant
to perturbations, but are slow to adapt and fail to account for non-linear and timedependent muscular and biomechanical changes (Resquín et al., 2016; Riess and
Abbas, 2000). Adaptive model-based closed-loop control approaches require
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extensive model configuration for each user, requiring extensive parametrization
and affecting performance over time if those parameters do change (Ferrarin et
al., 2001; Gwo-Ching Chang et al., 1997). Fuzzy logic approaches (Davoodi and
Andrews, 1998; Ibrahim et al., 2011) require delineation of control rules and may
not be able to account for unforeseen perturbations to the system.
Respiratory pacing adds another dimension of complexity compared to other FES
applications since residual intrinsic ventilatory activity may influence controller
performance. The presence of intrinsic muscle activation requires for the control
algorithm used to be able to account for the presence of the intrinsic drive and
either entrain to the intrinsic drive or cause entrainment of the intrinsic drive.
Otherwise, tracking errors are likely to occur as these two would conflict with one
another and adversely affect controller performance.
2.7 Pattern Generator Pattern Shaper control
Previously, an adaptive neuromorphic paradigm for FES closed-loop control had
been developed for cyclic lower limb locomotion (Abbas and Chizeck, 1991; Abbas
and Triolo, 1997; Fairchild et al., 2010; Ichihara et al., 2009; Kim et al., 2009; Riess
and Abbas, 2000). This adaptive neuromorphic controller consists of a pattern
generator (PG) and a pattern shaper (PS). The PS is a single layer neural network
with weighted, time-shifted, overlapping activation profiles. The output of the PS at
each time step is then obtained as a weighted summation of the neuron outputs at
that time step.
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Studies done to assess the PG/PS controller’s performance in lower limb control
included computational studies for parametrization of controller variables (Stites
and Abbas, 2000), comparisons against PID controller performance (Riess and
Abbas, 2000), and experimental studies in both animal and humans that showed
that the PG/PS controller was capable of producing muscle contractions that
followed the physiological movement pattern while adapting to muscle fatigue
(Abbas and Chizeck, 1995; Abbas and Triolo, 1997; Fairchild et al., 2010; Ichihara
et al., 2009; Kim et al., 2008).
The adaptive ventilatory controller developed in this dissertation is based on this
previously developed adaptive controller for locomotion. The following chapters of
this dissertation will explicitly describe how the controller has been adapted and
improved for the purpose of controlling ventilatory function through FES and its
assessment both in silico and in vivo.

23

CHAPTER 3
CONTROL OF BREATH VOLUME THROUGH THE USE OF AN ADAPTIVE
CLOSED-LOOP PATTERN SHAPER

3.1 Introduction
When the autonomic control of ventilation is compromised, such as with cervical
spinal cord injury or central hypoventilation syndrome, means of artificial ventilation
are often needed. Dependence on mechanical ventilation to treat hypoventilation
can cause a considerable impact on quality of life. Although mechanical ventilators
are widely used to treat respiratory insufficiency (Kacmarek, 2011), mechanical
ventilation can in itself have detrimental effects on lung health.(Claxton et al., 1998;
Ricard et al., 2003) Positive pressure mechanical ventilators have been reported
to cause alveolar damage and lead to diaphragm muscle atrophy, with studies
indicating onset of atrophy after 18 hours of mechanical ventilation.(Andrew
Shanely et al., 2002; Levine et al., 2008; Ricard et al., 2003; Zambon et al., 2016)
Restoration of ventilation through electrical stimulation (pacing) is an alternative to
mechanical ventilators in cases where the phrenic nerve is intact, but the pre-motor
neurons have been damaged or when the respiratory central pattern generator
(rCPG) has been compromised. Pacing can be accomplished through stimulating
cuff electrodes on the phrenic nerve, intramuscular electrodes in the diaphragm
muscle, or catheter-based transvenous electrodes.(Reynolds et al., 2017) A series
of stimulating pulses delivered to the target cause contraction of the diaphragm
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muscle and thus elicit a functional breath.(Chervin and Guilleminault, 1994;
DiMarco, 1999, 2009; Glenn et al., 1988; Onders, 2012) Pacing approaches have
the benefit of neural activation of the diaphragm to produce negative pressure
ventilation, eliciting a breath in a more physiological manner. Pacing could also
slow or reverse the development of muscle atrophy, and possibly promote central
neuroplasticity for improved recovery.(DiMarco, 2009; Masmoudi et al., 2017;
Onders, 2012; Onders et al., 2007)
Current commercially-available systems operate in an open-loop manner, in which
the clinician must determine and set stimulation parameters that are suitable for
ventilatory pacing for a given individual.(Onders, 2012) However, there is a need
to adjust the stimulation parameters for pacing at a short time-scale in response to
physiological and metabolic demand, postural load changes,(Winslow and
Rozovsky, 2003) and stimulation-induced muscle fatigue. Changes over the long
time-scale such as electrode encapsulation or muscle atrophy, should also be
accounted for.
The limitations of an open-loop system could be addressed by an adaptive closedloop bioelectronic control system that adjusts stimulation to provide sufficient
ventilation to the user. To achieve efficient and responsive ventilation, the
controller should be able to automatically and repeatably produce a suitable breath
volume profile and adapt respiratory rate with minimal technician intervention. As
an initial step to develop an adaptive ventilatory controller for diaphragmatic
pacing, the aims of the present study were the design and development of a
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neuromorphic closed-loop adaptive controller capable of achieving and
maintaining a desired breath volume profile at a pre-determined fixed respiratory
rate.
An adaptive ventilatory pacing controller, shown in Figure 1, was developed
following

a

neuromorphic

pattern

generator/pattern

shaper

(PG/PS)

architecture.(Abbas and Triolo, 1997; Jung, 2018; Kim et al., 2009) A
computational model for the chest and diaphragm in the adult rat was used for
initial development of the controller and for selection of suitable PS parameters. A
rodent model of incomplete spinal cord injury was used to assess the ability of the
controller to ameliorate hypoventilation. Hemisection of the spinal cord at the C2
level causes hemiparesis of the ipsilateral hemidiaphragm and leads to significant
reduction in tidal volume.(Doperalski et al., 2008; Dougherty et al., 2012a; Sandhu
et al., 2009) In vivo studies in both spinal cord intact and left C2-hemisected (left
C2hX) animals confirmed that PS-controlled adaptive pacing could achieve and
maintain a desired volume profile. In left C2hX animals, tidal volume was restored
to values observed prior to the hemisection. Pacing also caused a decrease in the
elevated end-tidal CO2 (etCO2) values that resulted from the reduced ventilation
after hemisection. Because breathing itself is dynamic, the development of a
similarly dynamic neuromorphic controller for ventilation represents an important
step in expansion of neurotechnology that is able to, ultimately, replicate and
replace autonomic function after ventilatory impairment.
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3.2 Methods
3.2.1 Animal care and surgical procedure
In vivo studies were conducted on spontaneously breathing, adult, male Sprague
Dawley rats (open loop stimulation n = 1, 415 g, 4.3 months old, adaptive
stimulation spinal cord intact n = 9, 372 ± 74 g, 4.1 ± 0.9 months old; adaptive
stimulation left C2hX n = 7; 419 ± 121 g, 4.4 ± 1.2 months old) with the approval
of the Institutional Animal Care and Use Committee of Florida International
University. Rats were initially anesthetized with intraperitoneal pentobarbital (50
mg/kg) followed by supplemental inhaled isoflurane (1.0 – 2.5%) in 100% O2. The
plane of anesthesia was assessed via a toe-pinch reflex. Body temperature was
maintained between 36-38 °C via a heating lamp. A pulse oximeter sensor
monitored SpO2. A tracheal tube was inserted after a tracheostomy and sutured to
the trachea. A small animal pneumotachometer (PTM Type HSE-73-0980,
Harvard Apparatus, Holliston, MA) connected directly to the tracheal tube
measured air flow. Flow was integrated (PI-1000, CWE Inc., Ardmore, PA) to
obtain breath volume. A capnograph (CapStar-100, CWE Inc., Ardmore, PA)
monitored end-tidal CO2 (etCO2) throughout the experiment. 30G stainless steel
needle electrodes were inserted subcutaneously to monitor cardiac activity via
electrocardiogram. Stainless steel wire intramuscular recording electrodes (SS304, 44 AWG, AM-Systems, Carlsborg, PA) were inserted below the tongue for
recording of genioglossus (GG) muscle activity in some animals (n=2). GG activity

27

was recorded to assess synchrony between the intrinsic inspiratory drive and
paced breaths.
A ventral incision provided access to the caudal aspect of the diaphragm muscle.
A handheld stimulator (DigiStim 3 plus, Neuro Technologies) with a blunted needle
delivered constant current pulses at 1 Hz to map the location of the neuromuscular
junction. Stimulation electrodes were implanted near this location. The peritoneal
incision remained open to provide visualization of the diaphragm during
assessment of muscle twitch thresholds, after which the incision was sutured
closed.
A lateral C2 hemisection was performed prior to stimulation in 7 rats to use as an
incomplete spinal cord injury (iSCI) model. A dorsal C2 laminectomy was
performed to expose the cervical spinal cord. Once exposed, a microscalpel was
used to perforate the dura and to sever the left half of the spinal cord at the C2
level. Observing a considerable decrease in tidal volume provided a functional
assessment of a proper hemisection. Spinal tissue was also collected for
histological assessment to ensure that the hemisection resulted in severance of all
descending phrenic pathways.
3.2.2 Diaphragmatic stimulation
Diaphragmatic pacing was conducted using single stranded, stainless steel
electrodes (SS-304, 44 AWG, AM-Systems, Carlsborg, PA) implanted bilaterally
through the abdominal fascia of the diaphragm or through the muscle itself with
the use of a suture needle (10 mm, 3/8th circle, cutting, Havel’s Inc., Cincinnati,
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OH). Stimulation was performed using a constant-current programmable
stimulator (FNS-16, CWE Inc., Ardmore, PA) delivering cathodic first, biphasic
current pulses of 200 µs/phase at 75Hz with amplitude modulated every 40 ms by
the adaptive PS controller. The 75 Hz stimulation frequency was shown to provide
tetanic contractions in rat skeletal muscle.(Fairchild et al., 2010; Jung et al., 2009)
Pulses delivered at 75 Hz were also found to consistently elicit effective tetanic
contractions of the diaphragm during preliminary trials and thus this pulse
frequency was maintained for all trials in this study. In all experimental trials the
initial current pulse amplitude was set to zero which automatically changed once
the PS controller was initiated. Current amplitude was determined by scaling the
PS controller output to the maximum limit for current amplitude set for each
stimulating channel. The maximum current amplitude was set for each stimulating
channel at 4 times the twitch threshold amplitude observed for each
hemidiaphragm during open-loop stimulation. Maximum current amplitude values
for the stimulated hemi-diaphragms ranged from 0.5 mA to 4.0 mA; the FNS-16
stimulator resolution for the current amplitude is 0.001 mA.
3.2.3 Experimental protocol
To assess the controller's ability to achieve a desired ventilatory profile in both
spinal cord intact and left C2hX rats, the controller was set to modulate stimulation
to match a desired breath volume profile with a constant cycle period. The desired
breath volume profile and cycle period were obtained from baseline ventilatory
data recorded for at least one minute prior to stimulation in each trial in spinal cord

29

intact animals and in multiple intermittent recordings prior to injury for the trials in
left C2hX animal. The desired breath volume profile was defined by averaging all
recorded breathing cycles except for sighs. The averaging algorithm automatically
excluded breaths identified as sighs based on preliminary data and literature that
describes sighs as being breaths with a tidal volume of at least twice the normal
tidal volume.(Wilhelm et al., 2001)
To illustrate the ability of the controller to modulate breath volume in spinal cord
intact animals, the desired breath volume profile was scaled by 120%. This scaling
factor was selected to match the approximately 20% increase in tidal volume
observed in preliminary studies on anesthetized spinal intact rats that were
exposed to a hypercapnic challenge. In left C2hX animals, the desired breath
volume profile was maintained at pre-hemisection values unless an increase in
desired breath volume was required to promote in-phase synchronization. The
duration of the desired breath cycle was set to match the duration of the breath
cycle prior to the trial; if required to improve the likelihood of synchronization, this
value was adjusted (within ± 10%). The desired breath volume profile was
maintained constant throughout the trial.
In trials in spinal cord intact animals, each trial consisted of at least one minute of
spontaneous breathing, followed by at least 100 cycles of pacing with an increased
desired breath volume of 120% of the baseline breath volume. There were one to
eight trials per spinal cord intact animal. In animals with iSCI, prior to hemisection,
trials were defined as multiple recordings of one minute each of spontaneous
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breathing (n=3 per rat, with the exception of rat 11 where n=2). After hemisection,
trials were defined as at least one minute of spontaneous breathing followed by at
least 200 pacing cycles. There were two to six trials post-hemisection per animal.
Expiratory muscles were not stimulated and therefore expiration was passive. A
rest period of 15 minutes was allowed between trials to allow the diaphragm to
recover from stimulation-induced fatigue. In left C2hX animals, a mechanical
ventilator was used to maintain proper ventilation during these rest periods and to
maintain etCO2 at nominal levels.
3.2.4 Performance measures
The adaptive controller adapts the stimulation output to the magnitude of the error
between the desired volume and the measured volume at a given instant. To
quantify the deviation from the desired volume and the achieved volume traces
over the portion of the respiratory cycle directly affected by inspiratory muscle
activation, the inspiratory root mean square error (iRMSE) % for each pacing cycle
was defined as

iRMSE =

100
1 q
ei 2

i =iins p
max(VD ) q

(1)

Where max(VD) is the peak value for the desired volume, 𝑖𝐼𝑁𝑆𝑃 denotes the time
step at the start of inspiration, q the number of time steps in the inspiratory phase
of the desired breath volume profile, and ei the instantaneous error at time step i.
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The basis of this error value across several pacing cycles has been used as an
indicator of controller accuracy in previous studies regarding evaluation of the
PG/PS controller (Abbas and Triolo, 1997; Riess and Abbas, 2000; Stites and
Abbas, 2000). In the current study, the number of pacing cycles required for iRMSE
% to fall below a certain threshold and maintain it for at least 10 pacing cycles
served as an indicator of controller speed of adaptation. A threshold of 5% iRMSE
was selected for simulation studies. In animal studies, due to inherent breath-tobreath variability in the inspiratory volume profile, the iRMSE threshold was
elevated to 10%. The mean and standard deviation of the iRMSE of the last 40
pacing cycles of the pacing period were used to assess controller performance.
In addition to the iRMSE measures, the effectiveness of pacing in left C2hX
animals was assessed by evaluating tidal volume and etCO2 during pacing. Values
for these measures were tabulated under pre-hemisection, post-hemisection
without pacing, and post-hemisection with pacing conditions from 40 pacing cycles
for tidal volume and 10 pacing cycles for etCO2 per condition. Analyzing tidal
volume over 40 cycles allowed assessment of the controller’s ability to maintain a
constant tidal volume over a large number of cycles, while selecting 10 cycles of
etCO2 allowed assessment of the transient response of etCO2 to pacing.
For tidal volume, the breath cycles post-hemisection without pacing were obtained
just prior to initializing pacing. For etCO2, the breath cycles post-hemisection were
collected after synchronization between the pacing and intrinsic breathing
occurred. This was done to utilize tidal volumes similar to eupnea, thus minimizing
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the potentially confounding effect of expiratory breath volume on etCO2 values.
Post-hemisection with pacing cycles were obtained prior to the end of the 200pacing cycle pacing period in both cases.
3.2.5 Histology
After completion of the experimental protocols each left C2hX animal was perfused
with phosphate buffer solution followed by 4% paraformaldehyde. The spinal cord
was extracted from the atlas to the C7 vertebra and placed in 4%
paraformaldehyde and then transferred to 30% sucrose for dehydration. Spinal
cords were then frozen and cryosectioned to obtain 10 µm longitudinal sections.
The presence of a gap in the ventrolateral tissue observed under light microscopy
of unstained sections was used to indicate completeness of the spinal cord
hemisection.
3.2.6 Experimental design and statistical analysis
A post-hoc t-test power analysis was performed to assess whether the number of
spinal cord intact (n = 9) and spinal cord left C2hX (n = 7) animals provided
sufficient power for statistical analysis of the number of pacing cycles required to
achieve 10% iRMSE or less. Based on descriptive statistics obtained for this
measure (spinal cord intact = 16.06 ± 6.66 pacing cycles, left C2hX = 58.8 ± 27.25
pacing cycles) and an alpha of 0.05, the test provided a power of 0.98 (Df = 14). A
repeated measures ANOVA power analysis was also performed post-hoc to
assess if 40 pacing cycles was sufficient to identify a difference in tidal volume
amongst the pre-hemisection, post-hemisection without pacing, and post-
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hemisection with pacing conditions in the left C2hX rats. A similar analysis was
done to determine if 10 pacing cycles of etCO2 were sufficient. The resulting power
was 1.00 and 0.95 for tidal volume and etCO2, respectively. All power analysis was
performed using G*Power 3.1.9.2.(Faul et al., 2007) Descriptive statistics were
obtained using SPSS (IBM, Armonk, NY).
To assess the effect of pacing on tidal volume and etCO 2 after hemisection, a
general linear mixed model (Cnaan et al., 1997) was used with fixed effects of trial
number and condition (spinal cord intact, hemisection without pacing, and
hemisection with pacing) and random intercept effects of both trial number and
measurement occasion (last 40 breath measurements within each trial for tidal
volume and last 10 breath measurements for etCO2). The generalized linear mixed
model was performed using SAS 9.4 (SAS Institute Inc., Cary, NC).
3.2.7 PG/PS controller design
The PG/PS controller utilized in this study is based on the original PG/PS controller
that was designed and used to control cyclic limb movements using functional
neuromuscular stimulation. The PG/PS controller had the ability to compensate for
muscle fatigue by adapting stimulation pulse parameters and charge delivery to
achieve the desired functional outcome.(Abbas and Chizeck, 1991; Abbas and
Triolo, 1997; Fairchild et al., 2010; Ichihara et al., 2009; Jung et al., 2009; Riess
and Abbas, 2000; Stites and Abbas, 2000) The PG module generates the pacing
cycle period while the PS module adapts to define stimulation parameters that elicit
a desired action. In the current study, a fixed frequency oscillator was used as the
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PG to produce a fixed respiratory frequency that did not change from breath-tobreath. The PS module consisted of a single-layer neural network with the output
profile of each neuron being a raised cosine function; the outputs of the neurons
in the set are time-shifted with respect to each other. In its current implementation,
the number of neurons was set as 25, with one reaching its peak every 40 ms
(which matched the frequency at which the controller sends an update to the
stimulator). To create a stimulation pulse train with frequency of 75 Hz, each
update to the stimulator resulted in the production of three pulses of identical
amplitude. Each neuron reaches its peak activity at a specific time-step but its
temporal profile overlaps across a specified number of neighboring neurons. The
width of the temporal profile determines the number of overlapping activation
profiles and is defined in the controller by the parameter na. The output, z(t), of the
PS at each time step is the weighted summation of the non-zero neuron outputs
at that time step and is given by
z (t ) =  ja=1 w j (t ) y j (t )
n

(2)

Where the output of a neuron j at time t is defined as 𝑦𝑗 (𝑡), with the weight for that
specific neuron set as 𝑤𝑗 (𝑡). The output, 𝑧(𝑡), is restricted to the range of values
between 0 and 1 and then scaled by the maximum current amplitude defined for
each channel.
Each scaling factor, or weight, for each neuronal output is modified based on an
instantaneous error between a pre-established target breath volume cycle profile
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and the measured volume signal. The controller works in a feedforward manner by
modifying each neuron’s weight at each time step based on the measured value
of error at that time. The change in weights for neuron j is

w j (t ) =  e(t ) i =p1
n

1
y j (t − tT )
np

(3)

Where 𝜂 is the learning rate, 𝑒(𝑡) is the instantaneous error at time t, T is the
update period, np is number of past activations over which the error is averaged,
and i the np index.
Computer simulations were carried out to elucidate the range of parameters over
which adaptation would be stable and errors minimized. These ranges were then
used in animal studies to assess in vivo implementation of the controller.
3.2.8 Musculoskeletal diaphragm model
A computational model of diaphragm and chest biomechanics was used as a
testbed to design and develop the PG/PS adaptive controller prior to in vivo
evaluation. The musculoskeletal model and PG/PS controller were implemented
in the LABVIEW programming environment using the Control Design and
Simulation module (National Instruments Inc., Austin, TX). The chest model is a
biomechanical model in which the mechanical action of diaphragm muscle
displacement is assumed to correspond linearly to breath volume.(Lessard, 2009;
Milhorn, 1966) A proportionality constant, kp, was implemented to calculate breath
volume from muscle displacement. The mechanical action of the diaphragm is
defined by the inertance of the chest system, mL, the elastance of the system, KL,
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and the damping coefficient of the system, BL. Chest biomechanics was described
mathematically as a function of diaphragm contractile force via the following
equation,

k p Fd ia

d 2x
dx
= mL
+ BL
+ KL x
dt
dt

(4)

Where the input to the model is the force exerted by the diaphragm muscle, Fdia,
and the output is the displacement of the diaphragm, x. The mechanical circuit is
shown in Figure 2(A).
The diaphragm muscle model was based off the multiplicative quadriceps muscle
model with reverse recruitment shown in Figure 2(B).(Abbas and Chizeck, 1991;
Teixeira et al., 1991) Briefly, the total force exerted by the muscle, 𝐹𝑑𝑖𝑎 , is given by
the product of a dynamic muscle activation model output Ak, force-length factor
AFL, and a force-velocity factor AFV.

Fd ia (t ) = Ak (t ) AF L (t ) AFV (t )

(5)

Intrinsically, fatigue-resistant fibers are recruited first while fast-fatigable fibers are
recruited later when there is a higher demand for recruitment of muscle fibers.
However, due to the nature of extraneural electrical stimulation in which larger
fibers have a lower threshold, the larger fast fatigable fibers are recruited before
the

slow

fatigue-resistant

fibers

are

activated

resulting

in

reverse

recruitment.(Peckham and Knutson, 2005) This reverse recruitment produces
nonlinear input/output properties that were modeled using
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r (t ) =  0 +  1[ Stim(t ) − D] +  2 [ Stim(t ) − D]2
+ 3[ Stim(t ) − D]3

(6)

in which muscle recruitment, r(t), is calculated to mimic the intrinsic recruitment
curve observed experimentally in previous studies in rats.(Mantilla et al., 2010) D
represents the dead band, or the pulse amplitude below which no fibers are
recruited, and the constants, 𝛾0, 𝛾1, and 𝛾3 were modified to obtain a cubic curve
that fit these experimental results.
The force generated as fiber recruitment increases is a dynamic process which
was modeled using a second-order autoregressive, moving average (ARMA)
model with input and output delays.(Abbas and Chizeck, 1991)

ak (t ) = a1 Ak (t − T ) + a2 Ak (t − 2T ) + b0r (t − T )

(7)

Constants 𝑎1 and 𝑎2 define the linear dynamics of the model, while 𝑏0 defines the
muscle input gain. The delay 𝑇, was based on the model update period of 14 ms.
The force-length component, 𝐴𝐹𝐿 , and force-velocity component, 𝐴𝐹𝑉 , serve as
scaling factors to the force generated by the dynamic model. Force-length factor
was estimated with a quadratic equation,

AF L (t ) = 1 −

[ L(t ) − L0 (t )]2
Lw 2

(8)

with 𝐿 being the length at instant 𝑡, 𝐿𝑜 the reference length, and 𝐿𝑤 the maximum
length of the muscle.
The force-velocity factor was obtained via
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AFV (t ) =

KV [Vma x − V (t )]
KV [Vm a x ] + V (t )

(9)

with KV being the force-velocity slope and Vmax the maximum shortening velocity.
Constants for all equations and their values can be found in Table 1.
3.2.9 Computational trials for parametrization of suitable controller parameters
A previous study has illustrated the ability of the PS controller to adapt across a
wide range of controller parameters.(Stites and Abbas, 2000) However, in this
study the PS was assigned to follow a trajectory for limb movement that differs
considerably in profile, amplitude, and duration from one derived from respiratory
volume. A LabVIEW implementation of the PS controller and musculoskeletal
model was used to carry out the computer simulations. All simulations utilized a
predetermined desired trajectory from a baseline volume profile obtained from
experimental data.
The controller parameters varied in computer simulation studies were: number of
active neurons at any one time-step, number of past neuron activations over which
to average the instantaneous error, and learning rate. The controller update
frequency was set at 25 Hz and the number of neurons was set to 25. Learning
rate values tested were 0.0001, 0.0005, 0.001, 0.002, 0.003, and 0.004. The
values tested for the number of active neurons tested ranged from 1 to 19 (in steps
of 2) and the values tested for the number of past activations ranged from 2 to 20
(in steps of 2). Each of these simulated trials were done for a length of 100 pacing
cycles.
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To determine the controller parameters suitable for fast, accurate, and stable
performance, only parameter triads that would pass selection criteria were
selected. These criteria were: iRMSE below 5% within 20 pacing cycles, mean
iRMSE below 5% and a standard deviation below 2.5% iRMSE after <5% iRMSE
was attained. Processing of trial results for parameter set selection was performed
using MATLAB (Mathworks Inc., Natick, MA).
3.3 Results
3.3.1 Simulations demonstrate the pattern shaping capabilities of the controller
Using the musculoskeletal model as a developmental testbed, a closed-loop
PG/PS controller capable of adapting and modulating the stimulation output to elicit
a desired breath volume profile was developed. Results from a sample simulation
trial using 3 active neurons with 6 past activation values with a learning rate of
0.001 are presented in Figure 3. In Figure 3(A, B), volume and stimulation traces
for the first ten pacing cycles show how the controller can adapt the stimulation
levels so that the measured volume profile matches a pre-set desired volume
profile. Figure 3(C) shows that in pacing cycles 91-100 the measured and desired
volume profiles still match closely. Figures 3(E) and 3(F) show how iRMSE and
charge delivered changed over a 100-pacing cycle trial period. When the trial
starts, a decrease in iRMSE to a value below 5% iRMSE by pacing cycle # 5 is
seen. For the rest of the trial, iRMSE remains well below 5% and finally decreases
to an average of 0.96% in the last 10 pacing cycles of the simulation trial. Charge
delivered per pacing cycle increases initially as the controller adapts to increase
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the elicited breath volume profile and match the desired profile. Given that the
controller is continuously adapting, charge delivered then decreases as the
controller fine tunes the neuronal weights to further reduce iRMSE. Once the error
is at a minimum, the charge delivered remains constant for the rest of the trial
unless there is a change in the error.
3.3.2 Synchronization between intrinsic breaths and paced breaths in vivo
In vivo trials demonstrated the ability of the controller to adapt to fatigue and reduce
inspiratory RMSE in both spinal cord intact and left C2hX anesthetized rats.
However, unlike in computational studies, the residual intrinsic respiratory drive
interacts with the controller in a manner that significantly affects the controller’s
performance. Figure 4, which shows the first 100 seconds of a trial, depicts how
the intrinsic respiratory drive interacts with the pacing after it is initiated. Initially
stimulation is set to zero as the controller has yet to adapt and increase stimulator
output. However, as the error values increase due to the mismatch in timing
between the intrinsic breaths and the paced breaths, the controller adapts
gradually increasing charge delivered during each pacing cycle. Eventually, the
intrinsic breaths synchronize with the pacing induced breaths.
3.3.3 Adaptive current modulation is able to achieve and maintain a desired
volume profile
After successful adaptation, the measured volume profile closely matches the
desired profile, as demonstrated by low iRMSE, and that performance is
maintained for the remainder of the trial (Figure 5). Figure 5(A) – 5(B) shows a
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comparison of the volume profile between a breath elicited using an open loop
approach with a square-shaped burst and a breath elicited using pulse amplitudes
determined by the PS controller after adaptation. The open-loop approach in
Figure 5(A), other than lacking adaptation to extrinsic factors, elicits a breath that
differs significantly from a natural breath. However, the breath elicited by the
adaptive PS controller in Figure 5(B) matches the desired breath closely. Trials in
three rats in a different study (data not provided here) showed a similar inability to
match the desired volume profile under open-loop control.
A summary of the iRMSE and charge per pacing cycle for all spinal cord intact
animal trials is presented in Figures 5(C) and 5(D), respectively. Entrainment with
synchronization usually occurred by pacing cycle 20 and, within 5 pacing cycles,
this resulted in an iRMSE of 10%. As seen in Figure 5(C), iRMSE remained below
10% for most of the trials, with the exceptions of periods where intrinsic
perturbations occurred. These events are marked by a sudden rise and drop in
iRMSE. In seven trials, pacing was performed for an extended duration of up to 15
minutes (not shown). These extended trials also showed iRMSE below 10%
throughout the trial when in synchrony. As shown in Figure 5(D), charge delivered
per pacing cycle increased substantially until entrainment and synchronization
occurred. After this initial period, the controller fine-tuned the stimulator output to
obtain the desired volume profile. The charge delivered remained relatively steady
for the rest of the trial, changing only when intrinsic perturbations occur.
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Figures 5(E) and 5(F) show a summary of the data from Figure 5(C). Figure 5(E)
shows the average number of pacing cycles each animal took to achieve the 10%
iRMSE threshold and maintain it for at least 10 pacing cycles. This value is heavily
dependent on how fast and robustly the intrinsic respiratory rhythm entrains to the
pacing.
Given that some of the factors that affect entrainment and synchronization differed
between animals, the variability in this value was high. However, the number of
pacing cycles required to reach this value among all spinal cord intact animals
were 16.06 ± 6.66 pacing cycles.
Figure 5(F) shows the average iRMSE % for the last ten pacing cycles of the 100pacing cycle trials for each animal (iRMSE10). On one trial with animal 9,
desynchronization occurred once during this ten- pacing cycle period; this resulted
in the outlier observed. All other trials remained with consistently low iRMSE 10 for
the last ten pacing cycles across all trials.
In left C2hX animals, the adaptive controller was able to elicit breath volume
profiles that were comparable to those observed prior to the injury. Figure 6 shows
the initial 100 seconds of a trial showing the adaptive pacing’s effect in a left C2hX
animal with the target breath volume being the breath volume profile collected prehemisection. Despite a considerable reduction in the rodent’s breath volume with
only the impaired intrinsic drive, the controller could adapt to sufficiently stimulate
the diaphragm muscle to attain the breath volume profile observed prehemisection. This breath volume profile was maintained for the duration of the trial.
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Nine trials across multiple animals were extended to last over 25 minutes to assess
longer periods of ventilatory pacing (not shown). Except for periods of
desynchronization between the paced and intrinsic breaths, iRMSE remained
below 10% in these extended trials.
Overall controller performance and stimulation results for left C2-hemisected
animals can be seen in Figure 7 and Figure 8. Across all left C2hX animals, iRMSE
after entrainment and synchronization remained at 10% or less as seen in Figure
7(A). The number of pacing cycles required to achieve an iRMSE of less than 10%
for more than 10 pacing cycles is shown in Figure 7(B). Overall, 58.8 ± 27.25
pacing cycles were required across all left C2hX animals to reach 10% iRMSE and
maintain it within the 200- pacing cycle trial period. This value exceeded 200
pacing cycles in two trials for animal 16 and thus those trials were excluded from
this average. The pacing cycle number to threshold in left C2hX animals was
higher in comparison to those of spinal cord intact animals, suggesting that spinal
cord injury has a detrimental effect on promotion of respiratory synchronization.
Results across all left C2hX animals and across all trials are shown in Figure 8.
The effect on tidal volume is shown in Figure 8(A). Tidal volume across all animals
was significantly higher during post-C2 hemisection with pacing (post-C2hXp) than
that during postC2 hemisection without pacing (post-C2hX) for the last 40 pacing
cycles of each trial (0.59 ml increase, p=<0.0001). Pre-hemisection (pre-C2hX)
tidal volume was not significantly different from post-C2 hemisection with pacing
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(0.05 ml difference, p=0.39). This shows the controller’s ability to closely match a
desired volume profile despite injury.
In most trials, pacing had an effect on etCO2 as shown in Figure 8(B). All three
conditions were mutually significantly different, with pre-hemisection values
lowest, post-C2 hemisection with pacing values higher, and post-C2 hemisection
after synchrony (post-C2hXs) values highest (pre-C2hX vs post-C2hXs difference
= 1.42%, p=<0.0001; pre-C2hX vs post-C2hXp difference = 0.75%, p=0.0001;
post-C2hXs vs post-C2hXp difference = 0.67%, p<0.0001). While the resulting
etCO2 was still well above the normal etCO2 range, this reduction does show that
adaptive pacing is able to have an effect on etCO 2. It is likely that etCO2 can be
further reduced to normative values with respiratory rate modulation once etCO 2
feedback is implemented.
Controller parameters differed to a certain extent amongst spinal cord intact
animals; however, this further shows the robustness of the controller under multiple
controller parameters. Table 2 shows the controller parameters across all spinal
cord intact animals. Controller parameters for all left C2hX animals were set to
na=3, np = 6, and η=0.001.
Figure 9(A) shows 15 seconds of a trial in a left C2hX rodent in which
synchronization was lost. The desired and actual volume profile for each breath
are shown in the top row. The muscle activity recorded from the genioglossus (GG)
muscle reflects the intrinsic respiratory drive,(Brouillette and Thach, 1980; Fregosi
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and Fuller, 1997; John et al., 2005) while the stimulation trace shows the timing at
which pacing occurred.
Synchronization between the desired and actual volume profiles is lost after the
fourth pacing cycle, with the GG muscle activating half a pacing cycle after pacing
occurs. However, this mismatch rapidly corrects itself after a few pacing cycles.
De-synchronization causes an increase in the error signal to the controller and thus
current amplitude delivered (not shown) increases.
Histological analysis confirmed injury to the descending respiratory pathways in all
left C2hX animals; a sample ventral spinal cord section from one animal is shown
in Figure 9(B). Ventilatory function was also assessed by functional comparison of
tidal volume prior to and after the hemisection. Hemisection led to an average
decrease in tidal volume of 0.64 ml (p<.0001).
3.3.4 Number of past activations, number of active neurons, and learning rate
determine controller stability, performance, and adaptation speed
A total of 500 computer simulation trials were completed, each with a different
permutation of learning rate, number of neurons, and past activations, to determine
suitable combinations of these controller parameters that would allow for fast,
accurate, and stable controller performance. Of these trials, a total of 39 parameter
sets matched the selection criteria of mean iRMSE of less than 5% within 20 pacing
cycles with a standard deviation of less than 2.5% iRMSE after 5% iRMSE had
been achieved. Figure 10(A) shows these parameters along with number of pacing
cycles required to lower iRMSE to less than 5%.
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Results from the simulations showed that faster learning rates increased
adaptation speed and thus reduce number of pacing cycles to reach the threshold.
However, faster learning rates also showed a decrease in stability. As learning rate
was increased, the number of acceptable parameter combinations decreased from
21 sets to only one set. The iRMSE standard deviation values of the last ten paced
cycles of each trial (iRMSE10), which are assumed to be inversely proportional to
stability, also showed an overall increase as learning rate increased (Figure 10(B)).
When selecting a learning rate to use in the experiments, it is necessary to
consider that decreased stability could pose a problem given the inherent
variability of the system and presence of non-ventilatory behavior. Thus, for in vivo
verification of the controller parameters, a learning rate that is low enough to
provide stability, yet high enough to provide sufficient adaptability, is desired.
These simulations determined a suitable range of parameters for various learning
rates. For the in vivo studies, a low learning rate capable of maintaining robustness
and stability is desired to prevent errors from propagating. Thus, a learning rate of
0.001 was deemed suitable. For this learning rate, 3 to 5 active neurons and 4 to
8 past activation values, were considered suitable parameter values as they had
the lowest values for iRMSE10 % while still showing low standard deviation values.
These ranges were found under the assumptions that muscle mechanics remain
constant over time, i.e. that there was no fatigue, and that the breath volume profile
selected as the desired trajectory is an ideal trajectory.
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The controller parameters that were ultimately implemented in the spinal cord
intact animal studies differed from those found computationally as the presence of
an intrinsic respiratory drive affected controller performance. This required
controller parameter tuning to improve synchronization and entrainment with the
intrinsic respiratory drive. However, the controller parameter trends that were
observed computationally were generally maintained across animals. Controller
parameters used can be found in Table 2
3.4 Discussion
The present study presents a novel neuromorphic closed-loop, adaptive controller
for ventilatory pacing capable of modulating stimulation parameters to elicit a
breath volume profile that follows a desired profile over hundreds of breaths. A
computational platform facilitated development of the controller and provided a
range of controller parameters that achieved satisfactory performance, accuracy,
and stability. Evaluation in spinal cord intact and left C2-hemisected rats validated
the parameters determined computationally. The Pattern Shaper (PS) controller
successfully reduced the error between measured and desired breath volume
profiles in the presence of a competing intrinsic respiratory drive and/or diaphragm
muscle fatigue. In left C2hX rats, the PS controller successfully restored breath
volume to levels observed prior to the injury while also reducing etCO 2 values.
These studies support the use of the closed-loop adaptive PS controller for
ventilatory pacing to achieve breath-by-breath control after spinal cord injury or
central hypoventilation syndrome.
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3.4.1 Computational studies provided a testbed for controller development and
characterization
The simulations carried out using biomechanical computational models illustrate
the benefits of utilizing computational models as test-bed platforms for the
development of neurotechnological algorithms prior to utilization in in vivo studies.
Here, the computational models ensured that the neuromorphic algorithm for
ventilatory control was able to properly adapt and maintain a desired breath
volume profile before any animal study was performed, substantially decreasing
development time and use of experimental resources. These computational
studies identified ranges of controller parameter values that resulted in fast,
accurate, and stable performance and identified interactions between these
parameters that affect adaptation performance.
The PS controller determines the amplitude of upcoming stimulation pulses as the
weighted summation of the output of all neurons in the network, however, only
neurons that have a non-zero output at any particular instant contribute to a
stimulation pulse. Since each neuron has non-zero output for a portion of the
breath cycle and the output profiles are shifted in time, the width of the output
profile is directly related to the number of active neurons. Low values for this
parameter localize the influence of each neuron but might also lead to unstable
behavior. However, stability can be improved by selecting an appropriate value for
the number of past-activations included in the summation term of the adaptation
algorithm. As shown in Figure 10, when using a low value for the number of active
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neurons, selecting a high value for the number of past activations was more likely
to meet performance specifications.
The learning rate, η, directly scales the change in neuronal weight in response to
each error measurement. While fast adaptation is generally desired, high learning
rates can produce large and rapid changes in weights that can compromise
stability or produce an under-damped response. With a low value for learning rate,
the controller reaches the target iRMSE more slowly, but then the system
performance remains stable.
These simulations suggest that for clinical deployment the controller would benefit
from a learning rate that is fast enough to adapt to provide sufficient ventilation
while being slow enough to remain stable.
3.4.2 Controller provided autonomous and individualized ventilatory pacing
Animals in this study varied in weight, stimulation twitch threshold, presence of
injury, and ventilatory drive as defined by etCO 2 levels. Irrespective of these
differences the PS controller autonomously adapted to achieve the desired
ventilatory profile for each individual. In rodents with partial diaphragm function due
to left C2 spinal cord hemisection, the controller adapted stimulation values to elicit
tidal volume profiles that matched those observed pre-hemisection. Furthermore,
the controller was able to elicit the same desired breath volume profile despite
differences in the un-paced breath volume between trials. This shows that the
adaptive controller can automatically personalize treatment regardless of the
efficacy of the intrinsic respiratory drive after injury.
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The incomplete spinal cord injury model used in this study also helps to highlight
the adaptive properties of the controller in that the desired breath volume profile
was attained regardless of a non-paralyzed hemidiaphragm contralateral to the C2
spinal hemisection. Stimulation, scaled to each hemidiaphragm’s twitch threshold,
was delivered to both left and right hemidiaphragms without differentiating between
paralyzed and non-paralyzed hemidiaphragms. This may have led to increased
activation of the hemidiaphragm contralateral to the injury. Despite this
asymmetrical activation, the controller was able to fine tune stimulation in such a
way that the desired breath volume profile was still attained and maintained. In
cases where both hemidiaphragms are affected, we expect the controller to
behave as in the spinal cord intact animals given that both hemidiaphragms would
be activated and contributing to ventilation.
Experiments shown here consisted only of acutely spinal C2-hemisected animals.
Thus, the effect of recovery from phenomena such as spinal shock, or
neuroplasticity in the form of the crossed-phrenic phenomenon, and respiratory
muscle atrophy after chronic injury were not addressed. However, inferences
regarding the controller’s advantages with regards to these conditions can be
made. The PS controller is able to adapt on a breath-by-breath basis and is thus
able to adapt in a matter of breaths to transient biomechanical changes that occur
after the spinal injury. The controller’s ability to adapt ventilation is not based on
explicit knowledge of the system’s mechanics, using only the elicited breath
volume as its controlled variable. Since changes in biomechanics affect the elicited
breath volume, these changes would be reflected in the breath volume signal
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sampled by the controller. The PS controller would then adapt stimulation output
to compensate for these changes, thus maintaining a desired breath volume profile
regardless of transient changes that might occur.
Previous animal studies (Kowalski et al., 2013; Nochomovitz et al., 1983; Walter
et al., 2011) have shown the feasibility of ventilatory pacing, while a number of
other studies have assessed viability and safety of ventilatory pacing in humans
for hypoventilation after spinal cord injury.(Chervin and Guilleminault, 1994;
DiMarco, 2009; DiMarco et al., 2002; Garara et al., 2016; Onders et al., 2011;
Posluszny et al., 2014; Zimmer et al., 2007) However, these animal and human
studies considered only the use of pulse trains with fixed stimulation parameters.
While open-loop controllers might elicit a desired tidal volume at the time of pacing
calibration, this fixed stimulation waveform must be manually selected for each
individual. The selected stimulation may not be suitable after muscles fatigue,
possibly leading to insufficient ventilation, discomfort, or pain. The PS controller
addresses this issue with its adaptive shape-defining abilities. The PS controller
achieves personalized pacing by using real-time measurements of performance
(volume) to adapt pulse amplitude within the pulse train, thus allowing it to activate
the diaphragm to elicit the breath volume profile desired.
In open-loop paradigms, manual adjustment of stimulation parameters is required
to maintain a constant tidal volume during short and long-term changes to the
muscle

or

electrode

interface,

such

as

muscle

fatigue

or

electrode

encapsulation.(Akers et al., 1997; Grill and Mortimer, 1994) The PS controller

52

continuously adapts to achieve a fixed ventilatory pattern regardless of any change
that might occur. Fatigue was not directly quantified in this study, but the presence
of a gradual increase in stimulation charge delivered and a constant low iRMSE
throughout the trial suggests that the controller was able to account for stimulationinduced fatigue of the diaphragm muscle. This effect was described in more detail
in previous studies in both rodents and humans concerning use of the PS controller
architecture for lower limb control.(Abbas and Triolo, 1997; Fairchild et al., 2010;
Kim et al., 2009) Additionally, electrical stimulation has shown to cause fatigue
onset on a faster time-scale than intrinsic neural activation.(Ratkevičius et al.,
1998) This ability to adapt diminishes or eliminates the need for clinical intervention
to adjust the stimulation parameters, reducing the cost, attendant time, and
inconvenience to the patient. Such consistency in ventilation might also expand
the range of activities that could be performed without increasing the risk of
hypoventilation or discomfort.
For the controller to be clinically viable in the presence of any degree of intact
respiratory drive, the paced and intrinsic breaths should be synchronized to
achieve effective and efficient ventilation. The onset of breaths produced by
diaphragmatic contraction due to stimulation may or may not coincide with the
onset of breaths due to the intrinsic respiratory drive. This is illustrated in figure 9,
where GG activity that reflects respiratory drive (Brouillette and Thach, 1980;
Fregosi and Fuller, 1997; John et al., 2005) is not synchronized with the pacing
signal.
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Although the PS controller does not have an explicit mechanism to achieve
synchronization, it was observed that the adaptive algorithm’s intrinsic adaptation
to error can promote entrainment and synchronization. This behavior occurred
both at the initiation of pacing and sporadically throughout pacing. Errors that result
from the temporal mismatch between the elicited and desired volume profile cause
an increase in stimulation output. When the increased stimulation in the paced
cycle matches an intrinsic inspiratory phase, a comparatively stronger
diaphragmatic contraction occurs, causing an overshoot of the peak volume
elicited. The increased pulmonary stretch receptor feedback likely triggers the
Hering-Breuer reflex through vagal afferents, which resets the phase of the
breathing cycle and produces entrainment and synchronization.(Muzzin et al.,
1992; Simon et al., 1999)
Loss of synchrony was observed in both spinal cord intact and left C2hX rats;
however, left C2hX animals also showed a higher incidence of these events and
required more pacing cycles to re-synchronize. In contrast with spinal cord intact
animals, all left C2hX animals had difficulty achieving initial phase synchronization;
with pacing cycles to 10% iRMSE lasting an average of 53 pacing cycles,
compared to 17.5 pacing cycles in spinal cord intact animals. One possible reason
for difficulty in entrainment and synchronization is that pacing in spinal cord intact
animals targeted a breath volume that was 20% higher than baseline, increasing
stretch receptor input to the rCPG thus strengthening the coupling between the
paced and intrinsic breaths. Meanwhile, the desired breath volume in left C2hX
animals was the same as their baseline breath volume leading to baseline levels
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of stretch receptor feedback to the rCPG and thus weaker coupling than in spinal
cord intact animals. Additionally, In left C2hX animals, the hemisection unilaterally
disrupts diaphragm stretch receptor-mediated feedback to the rCPG via phrenic
afferents,(Nair et al., 2017) possibly reducing the strength of the primary signal
mediating entrainment of the intrinsic drive by the electrical pacing.
The interaction between intrinsic respiratory drive and respiratory pacing is also
evident after cessation of pacing. In most animals, after cessation of pacing, a
reduction in tidal volume and increase in cycle period are observed. This reduction
in minute ventilation was considerably more pronounced immediately after
cessation and gradually returned to values similar to baseline in a period of 30 to
60 seconds. This suggests a decreased neuro-respiratory drive due to stimulationinduced hyperventilation and thus decreased chemoreceptor feedback to the
central drive. It was observed that this decrease in minute ventilation was less
pronounced in trials that experienced a large number of loss of entrainment events,
suggesting that a highly active intrinsic respiratory drive is the cause of loss of
entrainment to ventilatory pacing.
Future work assessing chronic respiratory pacing should consider the interplay
between pacing and a dynamic intrinsic respiratory drive, if one is present.
Previous studies have suggested technology that can be used to synchronize
artificial ventilation with intrinsic respiratory drive or to replicate its function. These
methods include development of a controllable stimulator with an update frequency
higher

than

the

stimulation

frequency
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and

a

real-time

processing

controller,(Castelli et al., 2017) implementation of a bio-inspired spiking neural
network model that follows intrinsic respiratory rate,(Zbrzeski et al., 2016)
predictive algorithms using body temperature and heart rate,(Kimura et al., 1992)
and breath-triggering through the use of genioglossus muscle activity.(Mercier et
al., 2017) However, these approaches have not yet been sufficiently developed or
investigated.
3.4.3 Dynamic control of etCO2 can lead to further control of ventilation
The observed decrease in etCO2 was lower than expected likely due to pacing that
elicited baseline levels of ventilation after spinal hemisection, which may have
been sufficient to avoid further increases in CO2, but not sufficient to completely
expel excess CO2. This effect was observed more sharply in animals which had
low baseline tidal volumes and as a result, lower paced ventilation. Thus, a greater
change in overall ventilation may be required to achieve a more pronounced decay
in etCO2. This could be achieved by automatic adjustments to respiratory rate. In
the current implementation of the controller, the PG portion of the controller
produced a fixed oscillatory pattern. A PG that responds to changes in etCO 2 and
adjusts the respiratory frequency could be developed, as a respiratory patterngenerator inspired model-based PG.
Future work will focus on developing a variable closed-loop PG capable of
responding to changes to etCO2 and integrating it with the PS controller presented
here. The PG would be based on a model of the biological rCPG to dictate the
desired ventilatory pattern. A chemoreceptor model would convert the incoming
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etCO2 signal into a neural drive that would feed into this rCPG model. The PS
portion of the controller would then proceed to adapt stimulation to achieve this
new ventilatory pattern. This approach would allow for a comprehensive
respiratory pacing controller capable of providing proper ventilation regardless of
metabolic demand variations, muscle-related changes, and individual differences
(Jung, 2018).
Although ventilatory pacing has been under development for over 70 years, and
has already been used clinically, there has been a lack of closed-loop controllers
for ventilatory pacing. Open-loop control has the potential to lead to inadequate
ventilation as the patient undergoes changes in their physiological state, such as
changes in metabolic demand and postural load, and changes in the electrodetissue interface, such as electrode encapsulation. The automation of initial
stimulation parameter selection and consequent adaptation on a breath-by-breath
basis allows for individualized closed-loop control of ventilatory pacing on a longterm time scale with adaptability to short-term changes.
Furthermore, this adaptive closed-loop control strategy would allow for gradual
reduction of stimulation following respiratory rehabilitation, eventually leading to
automatic weaning, thereby decreasing time spent in rehabilitative therapy and
potentially improving ventilatory outcome measures. The PS controller modulates
stimulation as a function of the error between the desired and measured volumes,
increasing stimulation if the measured volume is lower than the desired volume
and decreasing stimulation if the measured volume is larger. If the diaphragm
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muscle is gradually strengthened as a result of repeated electrical activation and
its contribution to the overall breath volume increases, the controller would respond
to the increased breath volume by decreasing stimulation output. If the trend
continues, the controller would eventually decrease stimulation until the patient
could independently maintain sufficient ventilation, thus autonomously weaning
the patient from ventilatory support.
3.5 Clinical significance
Respiratory pacing can serve an alternative to mechanical ventilation in cases of
respiratory insufficiency. Each patient, depending on their weight, requires
different breath volumes for adequate ventilation and breath-to-breath modulation
of ventilation to account for changing metabolic states. Current commerciallyavailable respiratory pacing systems are open-loop and require manual calibration
by a clinician or technician to set the stimulation levels to achieve the desired
breath volume. We present a closed-loop respiratory pacing controller that can
automatically determine the stimulation parameters needed to achieve a desired
breath volume and adapt this stimulation during an on-going breath. Experimental
studies in rodents show that the adaptive controller can achieve a desired breath
volume profile for a wide range of body weights, even after diaphragmatic
hemiparesis caused by spinal cord injury. This adaptive approach offers multiple
clinical advantages over current systems. The approach allows for a streamlined
automated set-up process that provides the required pacing regardless of patient
specific ventilatory biomechanics. During ongoing use, there would be a reduced
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risk of inadequate ventilation as the controller would adapt and respond to
physiological changes such as those on muscle fatigue or alteration in posture.
Furthermore, the adaptive controller could be used as a respiratory rehabilitation
tool to strengthen inspiratory muscles and allow automatic weaning from
mechanical ventilation.
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Tables

Table 1: Chest and diaphragm biomechanical model parameters
mL

1.8 g

a1

0.6679

BL

8.4 g∙s-1

a2

-0.1001

KL

11.5 g∙s-2

b0

20

kp

7 g∙cm3∙s-2

Lw

6 cm

γ0

0

L0

0 cm

γ1

0.01909

Vmax 48 cm∙s-1

γ2

-0.0001152

KV

0.2

γ3

2.6 x 10-7

D

3.5%
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Table 2: Controller parameters utilized in spinal cord intact animals

Animal #

Active

Past

Neurons Neurons

Learning
Rate

1

13

6

0.0003

2

7

2

0.001

3

7

4

0.0001

4

7

4

0.0001

5

11

6

0.0003

6

7

4

0.001

7

7

4

0.001

8

3

6

0.001

9

3

6

0.001
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Figures

Figure 1. Closed-loop controller architecture for use in experimental studies
for diaphragmatic control. The pattern generator sets a fixed respiratory cycle
period. The pattern shaper neural network adapts as a function of the
instantaneous error between the desired and measured breath volume profiles.
The summation of time-shifted neuronal outputs from the pattern shaper dictate
controller output to the stimulator.
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Figure 2. A diaphragm muscle model (A) and chest biomechanical model (B)
are used for simulation of closed-loop pacing of the diaphragm muscle. The
mechanical model output is the displacement of the diaphragm (x), which then
translates to volume through a conversion factor (k). The displacement and
velocity are delivered back into the muscle model to factor into the force-length
and force velocity contributions. The controller modulates stimulation delivered
based on the error between a desired volume and the output of the model.
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Figure 3. Adaptive PS controller effect in breath volume in a simulated trial.
Example of a simulation trial showing the controller adapting the stimulation output
(B, D) to match the measured volume (A,C, solid) to the desired volume (A,C,
dashed) during the initial stimulation (pacing cycles 1-10) and at end (pacing cycles
91-100) of a 100 second trial.(E) Inspiratory RMSE throughout 100 pacing cycles
in a simulated trial using controller parameters obtained from parametrization
(η=0.001, na = 3, np = 6). (F) The corresponding normalized charge delivered by
the controller as it adapted the stimulation output to match the targeted volume
profile.
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Figure 4. Adaptive PS controller implementation in a spinal intact animal. The
controller adapts stimulation output to match the measured volume (solid line) to
the desired volume (dotted line). The controller was turned on at 10 seconds (dark
grey vertical dashed line) with controller parameters (na = 3, np = 6, η = 0.001). The
controller was able to cause successful synchronization after 14 pacing cycles
(light grey vertical dashed line) and maintained low iRMSE thereafter.
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Figure 5. Ability of adaptive PS control to achieve a desired breath volume
profile in spinal intact animals. (A) Open-loop stimulation using a squareshaped stimulation burst elicited a breath profile (solid line) different from that of a
spontaneous breath (dashed line). (B) The adaptive controller modulated
stimulation to elicit a breath profile similar to a desired breath profile derived from
a spontaneous breath. (C) Average inspiratory Root Mean Square Error (iRMSE)
between the desired and measured breath volume profiles for each animal. iRMSE
is elevated at the initiation of the pacing due to lack of synchrony between the
breaths produced during intrinsic respiration and those elicited by pacing. After
synchrony, the controller is able to reduce and maintain a low iRMSE across all
animals. (D) Average charge delivered per pacing cycle per animal. The controller
tended to trigger entrainment by increasing stimulation output until synchronization
occurred. (E) Average iRMSE in the last 10 pacing cycles per trial for all animals.
iRMSE10 was maintained below 10% except for one trial for animal 9, in which a
desynchronization occurred during the last 10 pacing cycles. (F) Number of pacing
cycles per trial required to achieve the desired 10% threshold, including the pacing
cycles required to reach synchronization.
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Figure 6. Adaptive PS controller implementation in an animal with left C2
spinal cord hemisection. The dark grey dashed line depicts controller initiation.
The rodent is spontaneously breathing at a tidal volume of 1.8 ml before stimulation
while the desired tidal volume was set to 2.5 ml. After the 20 pacing cycles required
for entrainment and synchronization (light grey dashed line), the elicited volume
profile quickly matched the desired volume profile (dotted line). This increased
volume was maintained for the rest of the rest of the stimulation trial.
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Figure 7. Ability of adaptive PS control to achieve a desired breath volume
profile in animals with left C2 spinal cord hemisection. Left C2 spinal cord
hemisected animals took longer to achieve entrainment and synchrony between
the paced and spontaneous breaths than observed in intact animals. This effect
can be seen in (B) where the iRMSE was not reduced below 10% until very late in
the trial in some instances. However, as can be seen in (A), iRMSE averaged
around 10% for the duration of the trial.
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Figure 8. Effect of pacing on tidal volume and end-tidal CO2 across trials for
all left C2 spinal cord hemisected animals. Tidal volume and etCO2 prehemisection (pre-hX; solid line), post-hemisection without pacing (post-hX; empty
square), and post-hemisection with pacing (post-hXp, solid circle) conditions in
each trial for each animal. Pacing was able to restore tidal volume to target values
(empty circle) similar or larger than those observed prior to the injury (pre-hX vs.
post-hX difference = 0.64 ml, p<.0001; post-hXp vs. post-hX difference = 0.59 ml,
p<.0001). EtCO2 was also reduced in most cases during post-hemisection with
pacing. However, the amount reduced was not sufficiently large to match the
etCO2 values observed when pre-hemisection values were recorded (pre-hX vs
post-hXp difference = 0.73%, p=.0002; pre-hX vs. post-hX difference = 1.46%,
p<.0001; post-hX vs post-hXp difference = 0.73%, p<.0001). Pre-hemisection
values obtained from n = 3 trials, with the exception of rat 11 (n = 2 trials).
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Figure 9. Resynchronization between intrinsic respiration and diaphragm
pacing after a C2 spinal cord hemisection. (A) Loss and recovery of
synchronization between intrinsic respiration (breath volume, genioglossus EMG)
and diaphragm pacing (stimulation on/off, bottom, stimulation onset denoted by
grey dashed lines). De-synchronization leads to elevated error between measured
(solid) and desired (dashed) breath volume. The controller is capable of reestablishing synchronization after de- synchronization due to phase shift timing
between inspiratory timing of GG and pacing. (B) Sample histological section of
the ventral spinal cord following C2 lateral spinal cord hemisection. Spinal cord
tissue of injured animals was longitudinally cryosectioned in 15 µm sections and
analyzed to assess exactness of hemisection. Hemisection was also assessed
functionally by observing changes in tidal volume post-injury.
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Figure 10. Effects of varying learning rate, number of active neurons, and
number of past activations on PS controller performance as determined by
simulations. (A) Solid dots indicate suitable parameter configurations led to
adaptation that met the acceptance criteria of achieving and maintaining a 5%
inspiratory RMSE within 20 pacing cycles while maintaining a standard deviation
below 2.5% throughout 100 pacing cycles for several learning rates (η). Dot color
denotes number of pacing cycles required to meet an inspiratory RMSE value of
5%. (B) Parameter trends obtained from simulation studies. Plots show effect on
RMSE10 with respect to number of past activation values (np) for several widths of
the activation function given by na (1 na = blue dashed; 3 na = orange dashed
dotted; 5 na = yellow dotted; 7 na = green solid; 9 na =light blue)
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CHAPTER 4
CONTROL OF BREATH VOLUME AND RESPIRATORY RATE THROUGH THE
USE OF AN ADAPTIVE CLOSED-LOOP PATTERN GENERATOR PATTERN
SHAPER CONTROLLER

4.1 Introduction
Ventilation is a highly dynamic process through which the mammalian brain
maintains adequate respiration. However, disease, trauma, or disorders in the
brainstem, spinal cord, or effector muscles and their innervating nerves, may bring
about impairment of ventilation or complete inability to control the ventilatory
process and lead to hypoventilation. Hypoventilation often leads to hypoxia and
hypercapnia, which in severe cases may disrupt homeostasis, cause brain
damage, and eventually lead to death (Cragg and Drysdale, 1983; Roussos and
Koutsoukou, 2003; Tiruvoipati et al., 2017; West and Luke, 2016). Mechanical
ventilation is usually the de-facto approach to restore and maintain proper
ventilatory function and prevent hypoventilation. Mechanical ventilation is effective
in that air is constantly and reliably delivered to the pulmonary airways independent
of the person’s indigenous ventilatory capabilities. However, mechanical
ventilation poses some drawbacks. Positive pressure from the mechanical
ventilator cycles air through the alveoli. Under this process, a decreased
respiratory drive reduces activity of the respiratory muscles, which may lead to
muscle atrophy. Atrophy may increase the time required for weaning from
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mechanical ventilation in cases where recovery is possible (Andrew Shanely et al.,
2002; Levine et al., 2008; Vassilakopoulos, 2012; Zambon et al., 2016).
Furthermore, a risk of alveolar damage due to elevated positive air pressure is
present during mechanical ventilation as shown by several studies (Claxton et al.,
1998; Levine et al., 2008; Zambon et al., 2016).
Respiratory pacing which consists of electrically stimulating the diaphragm or its
innervating nerve, the phrenic nerve, has been shown to be an alternative to
mechanical ventilation. Appropriate stimulation causes a contraction of the
diaphragm eliciting inspiration and can elicit a functional breath (DiMarco, 2005,
2018; Le Pimpec-Barthes et al., 2016; Nochomovitz et al., 1983; Onders, 2012;
Peterson et al., 1986). Respiratory pacing overcomes the drawbacks of
mechanical ventilation. Respiratory pacing ameliorates atrophy since the muscle
is recruited electrically at every breath, reduces risk of lung damage since
electrically-driven diaphragm activation draws air into the alveoli through negative
pressure (Brown et al., 2006; DiMarco, 2005; Onders, 2012), and does not require
intubation. However, commercially available respiratory pacing systems lack the
ability to adjust the stimulation parameters in response to changes in the user’s
chest biomechanics and/or physiological metabolic changes. The stimulation
parameters are set in a clinic by a clinician or medical technician familiar with the
pacing technology (Jarosz et al., 2012). Furthermore, changes in the tissueelectrode interface or mechanical properties of the ventilatory system over days or
weeks require re-tuning the system (Glenn et al., 1976). Most importantly, the preset stimulation parameters preclude the ability of the pacing to automatically
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change in response to altered respiratory demands consequent to metabolic
changes.
An adaptive closed-loop controller for respiratory pacing that is able to modulate
stimulation parameters to ensure a desired breath volume pattern is maintained
has been previously developed and described in Chapter 3 (Siu et al., 2019). The
controller utilized an Pattern Shaper (PS) scheme based on an adaptive artificial
neural network originally designed for lower limb locomotor control in rodents and
in humans (Abbas and Chizeck, 1991, 1995; Fairchild et al., 2010; Ichihara et al.,
2009; Kim et al., 2009; Riess and Abbas, 2000). This adaptive PS controller was
modified for diaphragm pacing use and was able to evoke a desired breathvolume, restoring eupnic ventilation in rats with diaphragm hemiparesis. However,
eupnic ventilation was unable to account for the increased arterial CO2 levels that
resulted from decreased ventilation. Thus, it is required for the controller to be able
to elicit a proper hypercapnic response, where both breath volume and respiratory
rate increase in comparison to eupnic ventilation, to achieve normocapnia.
For unimpaired breathing, the respiratory central pattern generator (rCPG), a
network of interconnected neuronal populations located in the brainstem,
generates a ventilatory pattern in response to CO2 chemoreceptor activity, lung
mechanoreceptors and other neural inputs originating from the cortex and
amygdala (Feldman and Kam, 2015; Molkov et al., 2017; Richter and Smith, 2014).
The generated ventilatory pattern contains information about both breath volume
and breath cycle duration. In hypercapnia, an elevated arterial CO 2 concentration
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causes an increase in CO2 chemoreceptor activity. This increase in chemoreceptor
activity increases rCPG activity, resulting in elevated breath volume and decreased
cycle duration (Molkov et al., 2014a, 2014b). The rise in ventilation improves the
efficacy at which CO2 is removed from circulation, eventually causing arterial CO2
concentration to decrease, reducing chemoreceptor activity, and finally reducing
ventilation to eupneic values (West and Luke, 2016).
The objective of the work presented here was to develop a closed-loop controller
capable of, through respiratory pacing, modulating ventilation in a manner that is
similar to that of physiological control of ventilation. This was accomplished by
developing a neuromorphic closed-loop adaptive controller that generates an
appropriate ventilatory pattern automatically in response to changes in partial
pressure of arterial CO2 (PaCO2) levels and then evokes this response through
modulation of the stimulation parameters as needed. This approach allows for
generation of the desired dynamic volume profile within a given breath, allowing
the user to be properly ventilated whenever they are in a situation in which
respiratory demand differs from when the system was tuned.
Similar to a previously developed version of the controller, the closed-loop PG/PS
controller implements a single layer neural network, described in Chapter 3 (Siu et
al., 2019), to serve as a pattern shaper module. However, in this study, a
mathematical model of the rCPG (Botros and Bruce, 1990)serves as the basis for
the pattern generator module to determine the appropriate ventilatory response to
changes in PaCO2. The rCPG model was replicated, modified, and integrated with
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a chemoreceptor model and a pulmonary stretch receptor model to complete the
PG module. The PG module was then coupled with the existing PS controller. The
PG/PS controller was assessed in silico to ensure adequate functionality prior to
in vivo studies. The controller’s ability to control for changes in PaCO2 was
assessed in vivo in two animal models of increased PaCO2 caused by
hypoventilation. Hypoventilation was induced either by repressing central control
of ventilation through use of supplementary isoflurane anesthesia (Dardai and
Heavner, 1987; Imai et al., 1999; Sollevi and Lindahl, 1995) or by reducing
inspiratory capacity through paresis of the left diaphragm via a left C2 spinal cord
hemisection (left C2hX) (Doperalski et al., 2008; Dougherty et al., 2012b; Gill et
al., 2014; Sandhu et al., 2009; Siu et al., 2019). These in vivo studies confirmed
that the controller was able to adequately respond to changes in PaCO2 by
generating a proper ventilatory response and matching that response through
modulation of stimulation parameters to eventually reduce PaCO2 to normocapnic
values.
This biologically-inspired adaptive closed-loop respiratory pacing controller is the
first ever approach for management of PaCO2 for respiratory pacing applications.
Closed-loop control of PaCO2 in people with ventilatory impairments would not only
permit patients with respiratory pacers to alleviate concerns about inadequate
ventilation during everyday tasks but may also allow patients without ambulatory
impairments to lead a more active lifestyle without risk of hypoventilation; leading
to improvements in health and quality of life.
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4.2 Methods
4.2.1 Animal care and surgical procedure
Spontaneously breathing, adult, male Sprague-Dawley rats were used to assess
PG/PS controller performance in spinal cord intact rats (n = 7, 411 ± 91 g., 3.6 ±
0.9 months) and left C2hX rats (n = 6, 390 ± 80 g., 3.4 ± 0.8 months). Animal use
was approved by the Institutional Animal Care and Use Committee of Florida
International University. Rats were anesthetized via subcutaneous delivery of
urethane (1.5 g/kg) and supplemental isoflurane (0.2 – 1.5% in 100% O2). The
plane of anesthesia was evaluated via the toe-pinch reflex and assessment of
breathing rate and heart rate. A closed-loop heating plate (TCAT-2AC, Physitemp,
Clifton, NJ) maintained body temperature at 37-38°F by monitoring temperature
through a rectal probe. A tracheostomy was performed to monitor air flow through
the lungs and measure it using a small in-line animal pneumotachometer (PTM
Type HSE-73-0980, Harvard Apparatus, Holliston, MA). Integration of air flow (0.2
s time constant) through a hardware integrator (PI-1000, CWE Inc, Ardmore, PA)
provided a measure of volume. End-tidal CO2 (etCO2) served as a measure of
PaCO2 and was monitored through a side-stream capnograph (CapStar-100, CWE
Inc., Ardmore, PA). Electrocardiography was performed using 30G stainless steel
needles inserted subcutaneously in the chest and abdomen for monitoring of plane
of anesthesia and overall rat health. To assess controller performance after
hemiparesis induced hypoventilation, a left C2 spinal cord hemisection was
performed on one subset of rats (n = 6). To assess completeness of injury,
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electromyograms (EMG) of the hemidiaphragm ipsilateral to the injury were
obtained during the spinal cord hemisection procedure and for several minutes
later. Spinal cord tissue was processed for visual assessment of completeness of
spinal cord hemisection through light microscopy as described in Chapter 3.
4.2.2 Diaphragm stimulation
The diaphragm muscle was stimulated bilaterally through single-stranded,
stainless steel electrodes (SS-304, 44 AWG, AM-Systems, Carlsborg, PA)
implanted intramuscularly in each hemidiaphragm as described in Chapter 3. A
constant-current stimulator (FNS-16, CWE Inc., Ardmore PA) delivered biphasic
cathodic-first stimulation pulses at a current amplitude determined by the
controller, a fixed pulse width of 200 µs/phase, inter-phase interval of 80 µs, and
pulse frequency of 72 Hz as described in Chapter 3. The current amplitude
determined by the controller is scaled based on the muscle fiber twitch threshold
collected during electrode implantation. Twitch threshold was obtained through
visual observation of minimal twitch using a single biphasic pulse with the
stimulation parameters mentioned above. Trials lasted for 900 sec or more.
4.2.3 Experimental protocol
Two groups of hypoventilated rats were utilized to assess whether the PG/PS
could autonomously control breath volume and respiratory rate to regulate PaCO2.
One group consisted of spinal cord intact animals undergoing ventilatory
depression via delivery of supplemental isoflurane. Given that isoflurane is a
respiratory depressant (Dardai and Heavner, 1987; Eikermann et al., 2008; Imai
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et al., 1999), supplemental isoflurane was delivered (+1.5% in 100% O2) to
suppress ventilation and thereby induce hypercapnia. Once 7% etCO 2 or more
was reached, the PG/PS controller was initiated and its ability to respond to
hypercapnia and reduce etCO2 closer to normocapnia (5 ± 0.5%) was assessed.
The PG/PS controller was considered to be successful if it reduced and maintained
etCO2 to within the normocapnic range.
To assess controller performance when hypoventilation resulted from a traumatic
spinal cord injury (SCI), we used a left C2 spinal hemisection model (Doperalski et
al., 2008; Lane et al., 2009; Sandhu et al., 2009; Siu et al., 2019). Spinal
hemisection from the C2 to C5 leads to hemiparesis of the hemidiaphragm
ipsilateral to the injury. This results in hypoventilation due to reduced inspiratory
muscle activity. After each trial, left C2 spinal cord hemisected rats were allowed
to rest for at least 30 minutes between trials to both recover from electrical
stimulation-induced muscle fatigue and for them to become hypercapnic due to
reduced inspiratory capacity after hemiparesis. If hypercapnia exceeded 7%
before 30 minutes had elapsed, mechanical ventilation was applied to prevent
etCO2 from exceeding 7%. Mechanical ventilation was required twice for rat 2 prior
to trial 3 and 5.
In all animal trials, the desired ventilatory pattern was determined by the PG
module of the controller based on etCO2 feedback and animal body weight as
described in the following section.
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4.2.4 Performance measures
The performance of the PG/PS controller was evaluated in terms of its ability to
determine and evoke an adequate ventilatory behavior in response to elevations
in the sampled etCO2 values, and in its ability to reduce etCO2 values towards
normocapnic levels and maintain normocapnia throughout the trial. The PG/PS
controller’s ability to determine and evoke a desired ventilatory output was
assessed by observing whether the elicited minute ventilation was directly
proportional to the measured etCO2. The PG/PS controller performance and its
ability to achieve and maintain the desired ventilatory pattern was determined by
measuring the inspiratory root mean square error (iRMSE) values throughout the
trial. Finally, etCO2 values after pacing indicated whether the model-guided
ventilatory profile generated by the PG could be used to control PaCO2. The first
20 cycles of iRMSE after entrainment and the last 20 cycles of the trial were
compared to assess whether controller performance declined over time. The
controller’s ability to decrease PaCO2 and achieve normocapnia was determined
by average decrease in etCO2 from the 10 breath cycles obtained after pacing was
initiated and entrainment had occurred to the last 10 cycles of the 1000 cycle trial.
4.2.5 Statistical analysis
A general linear mixed model (Cnaan et al., 1997) was used to assess the effect
of PG/PS controlled pacing on PaCO2. Fixed effects of trial number and condition
(prior to pacing and after pacing) and random intercept effects of both trial number
and measurement occasion (last 20 breath measurements within each trial). All
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descriptive statistics are given in the form of mean ± standard deviation. The
generalized linear mixed model was performed using SAS 9.4 (SAS Institute Inc.,
Cary, NC).
4.2.6 PG/PS Controller design
The PG/PS controller design is based on the biological ventilatory control scheme,
where the PG generates a model-based ventilatory pattern and the PS adapts
stimulation parameters to evoke the desired ventilatory pattern in response to
dynamic changes in PaCO2 levels. The design of the PG/PS controller can be seen
in Figure 11. For this adaptive ventilatory controller the PG module utilizes a
triphasic oscillatory network developed by Botros and Bruce to model the
respiratory central pattern generator (Botros and Bruce, 1990). This network is
composed of five interconnected neuronal populations; most of the synapses are
inhibitory. The activity of each of these populations is maximal at different phases
of the respiratory cycle, these being early inspiratory, inspiratory, late-inspiratory,
post-inspiratory, and expiratory. These populations receive mostly inhibitory input
from each other as well as from other external inputs depending on the population,
such as chemoreceptors and pulmonary stretch receptors. The equations for this
oscillating respiratory network are,
𝑑𝐼
𝑑𝑡
𝑑𝐿
𝑑𝑡
𝑑𝑃
𝑑𝑡

= −𝑎𝐼 𝐼 − 𝑊𝐸𝐼 𝑆(𝐸) − 𝑊𝑃𝐼 𝑆(𝑃) − 𝑊𝐿𝐼 𝑆(𝐿) + 𝑊𝐼𝐼 𝑆(𝐼) + 𝑛𝐶𝑂2 𝐵𝐼

(10)

= −𝑎𝐿 𝐿 + 𝑊𝐼𝐿 𝑆(𝐼) − 𝑊𝐸𝐿 𝑆(𝐸) − 𝑊𝑅𝐿 𝑆(𝑅) + 𝑊𝐿𝐿 𝑆(𝐿) + 𝐵𝐿 + 𝑊𝑣𝐿 𝑣

(11)

= −𝑎𝑃 𝑃 − 𝑊𝐸𝑃 𝑆(𝐸) − 𝑊𝑅𝑃 𝑆(𝑅) + 𝑊𝑃𝑃 𝑆(𝑃) + 𝑛𝐶𝑂2 𝐵𝑃

(12)
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𝑑𝐸
𝑑𝑡
𝑑𝑅
𝑑𝑡

= −𝑎𝐸 𝐸 − 𝑊𝐼𝐸 𝑆(𝐼) − 𝑊𝑅𝐸 𝑆(𝑅) − 𝑊𝐸𝐸 𝑆(𝐸) + 𝑛𝑐𝑜2 𝐵𝐸

(13)

= −𝑎𝑅 𝑅 − 𝑊𝐼𝑅 𝑆(𝐼) − 𝑊𝑃𝑅 𝑆(𝑃) + 𝑊𝑅𝑅 𝑆(𝑅)+𝑛𝐶𝑂2 𝐵𝑅 + 𝑊𝑣𝑅 𝑣

(14)

Where I, L, P, E, and R represent the inspiratory, late-inspiratory, post-inspiratory,
expiratory, and early inspiratory neuronal populations, respectively, while v
represents the input from the vagus nerve which carries pulmonary stretch
receptor information. The self-decay term denoting the rate of decay is defined by
ai, where i is the respective neuronal population. This term allows for silencing of
the i-population when no input is present. Wji refers to the gain of the signal, or
weight, of the j neuron to the i neuron, whereas Wii is the self-activation factor. Bi
refers to the weight of the chemoreceptor signal, nCO2, which is considered to
change linearly with PaCO2. To convert firing frequency of the neuronal population
to population activity, a sigmoid function, S, is used. This S function is as follows,
𝑆(𝑋) = 𝐾 ∙ 𝛼 + (1 − 𝐾) ∙ 𝛽
𝛼(𝑋) = {

min(𝑋, 4)
0

(15)

≥0
<0

(16)

4

𝛽(𝑋) = 1+𝑒 −1.75∙(𝑋−2)

(17)

Where X is the firing frequency and K is a constant that determines the steepness
of the function.
The chemoreceptor input, nCO2, is given as a linear step-wise function of PaCO2:
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𝑛𝐶𝑂2

𝑃𝑎 𝐶𝑂2 > 35
𝑛𝐶𝑂2 = 0.2
= {45 < 𝑃𝑎 𝐶𝑂2 < 35 𝑛𝐶𝑂2 = (𝑃𝑎𝐶𝑂2 ∙ 0.072) − 2.32
𝑃𝑎 𝐶𝑂2 < 45
𝑛𝐶𝑂2 = 1.72

(18)

The limits of 0.2 and 1.72 were set as a result of a set of preliminary simulations
performed on the rCPG model to obtain the minimum and maximum nCO2 values
at which a physiologically-relevant response was obtained. The linear function
constants were set so that a linear response between a P aCO2 of 35 to 45 mmHg
is maintained.
An exponential moving average of the peak PaCO2 value sampled by the PG/PS
controller each cycle is used by the chemoreceptor model to derive neural CO 2
input. To prevent instability caused by abrupt changes in PaCO2 due to non-eupnic
breaths such as sighs or gasps, a long time constant of 8 sec was used. This was
determined through simulations which are described in later sections.
To represent the pulmonary stretch receptor input, v, a one-dimensional model of
chest biomechanics was used (Lessard, 2009; Milhorn, 1966). This model is as
below,
𝑘𝑑 𝑁 = 𝑚𝐿 𝑥̈ + 𝐵𝐿 𝑥̇ + 𝐾𝐿 𝑥

(19)

Where x is diaphragm displacement, mL corresponds to diaphragm mass, BL to a
damping constant, and KL to elastance. N refers to neural input from the inspiratory
population of the rCPG, and kd is a proportionality constant that translates
displacement to mechanoreceptor output. Aside from providing the vagal feedback
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necessary to birth the oscillatory behavior, this biomechanical model continuously
provides a desired trajectory for the PS module.
The PS module for respiratory control has been described in Chapter 3. The PS
module aims to determine adequate stimulation parameters to elicit a specified
breath volume profile. In previous studies, this desired profile was preset based on
baseline breath volumes and profiles for each rat; here, the desired profile was
generated by the previously described PG module. Briefly, the PS consists of a
single-layered neural network with time-shifted activation profiles. The output of
the controller is a value from 0 to 1 which is multiplied by the maximum allowed
current amplitude. The controller output to the stimulator, z, is given by
𝑛

𝑎
𝑧(𝑡) = ∑𝑗=1
𝑤𝑗 (𝑡)𝑦𝑗 (𝑡)

(20)

The output is defined by the summation of the output of all weighted active
neurons, na. Neuronal weights are given by wj.
The PS uses a comparator to define the error at any time t, e(t), between the
desired volume trajectory defined by the PG module and the measured volume
profile. The change in weight, Δwj, for all neurons at time t is defined by
𝑛

1

Δ𝑤𝑗 (𝑡) = 𝜂𝑒(𝑡) ∑𝑘𝑝𝑝=1 𝑛 𝑦𝑗 (𝑡 − 𝑘𝑝 𝑇)

(21)

𝑝

Where η is the learning rate, np is the number of past activations over which the
error will be time averaged to account for delays in activation, and yj(t-kpT) is the
output of neuron j at previous times. Hence, the error at time t affects all neurons
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that are currently active, with the most active neuron at time t receiving the largest
alteration in weight.
The PG/PS controller was programmed and implemented in LabVIEW (National
Instruments, Austin, TX) for both experimental and computational studies. All
controller constants can be found in Table 1. In animal studies, the output of the
controller was scaled to four times the twitch threshold and sent to a programmable
stimulator as described in Chapter 3.
4.2.7 Computational platform for controller development
The PG/PS controller was developed and validated computationally though a
software-in-loop approach (SIL) approach prior to in vivo assessment. A
comprehensive rat computational model containing biomechanical, muscular, and
CO2 dynamics was developed based on a previously published model for rat
biomechanical and muscular responses as in Chapter 3. A computational model
for CO2 generation in humans (Lessard, 2009; Milhorn, 1966; Topor et al., 2007)
was adapted and scaled to match rat normative values found in literature (Molkov
et al., 2014a; Whitehead et al., 1999) and integrated with the biomechanical model.
The organization of these models and their integration with the adaptive PG/PS
controller is illustrated in Figure 12. A list of constants and variables used for these
models can be found in Table 1.
The model describing CO2 dynamics is based on a CO2 compartmental model
containing a general body tissue compartment, a brain compartment, and a lung
compartment with appropriate CO2 transport delays (Molkov et al., 2014a). The
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body tissue and brain compartments produce CO2 based on compartment volumes
and a rate of CO2 production as described below
𝑉𝑇

𝑑𝐶𝑇
𝑑𝑡

= 𝑀𝑇 + 𝑄(𝐶𝐴𝑇 + 𝐶𝑇 )

(22)

Where T represents brain tissue or body tissue, depending on the compartment.
The concentration of CO2 of the compartment, CT, is given by volume of the
compartment, metabolic rate of the compartment, Ṁ, given as CO2 production rate,
perfusion through the compartment, Q, and CO2 concentration from the arterioles
to the compartment tissue, CAT. The concentration from both compartments is then
scaled by their respective perfusion rates and summed to represent total venous
CO2 concentration, CV. This value is then sent to the lung compartment defined by
𝑑𝑉𝐶𝑎
𝑑𝑡

={

𝑄(𝐶𝑉 − 𝐶𝑎 ) + 𝑉̇ 𝐶𝑖𝑛
𝑄(𝐶𝑉 − 𝐶𝑎 ) + 𝑉̇ 𝐶𝑎

𝑉̇ ≥ 0
𝑉̇ < 0

(23)

Where arterial CO2 concentration is given by the difference between arterial CO2
concentration and venous CO2 concentration multiplied by total perfusion, Q, and
during inspiration added to the inspired CO2 concentration or, at any other point,
arterial CO2 concentration.
4.2.8 Computational studies for PG/PS development
Assessment of the controller was carried out in the computational testbed
previously described. To first ensure the PG module responded appropriately to
changes in PaCO2, a range of PaCO2 values from 20 to 60 mmHg were delivered
to the PG through the chemoreceptor model. PaCO2 remained constant
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throughout a given simulation run. A proportional increase in minute ventilation for
each increase in PaCO2 would indicate that the PG module is able to respond
accordingly to changes in CO2.
The stability of the response to CO2 is dependent on the stability of the measured
signal. To reduce the possibility of controller instability due to sighs, shallow
breaths, airway occlusion, or apnea, an exponential moving averager (EMA) was
implemented. The time constant of the EMA was selected via simulated trials
assessing the controller’s response to two different physiological scenarios,
sudden increase in metabolic demand and apnea. The sudden increase in
metabolic demand was modelled by increasing CO2 production in the tissue by
50% at 180 sec after pacing initiation. Apnea was simulated by setting diaphragm
activation to zero for one cycle 300 sec after pacing initiation. Time constants of 1,
2, 4, 6, 8, 10, 15, 20, 25, and 30 sec were used for the EMA. The response was
assessed by calculating the root mean square error (RMSE) between the
measured PaCO2 response and a desired CO2 response from 5 sec prior to the
increase in CO2 rate production to 60 sec after the apnea is induced. A low
standard deviation in RMSE would imply better stability after perturbation.
To assess the controller’s ability to control ventilation reliably in response to
changes in PaCO2 in a closed-loop manner, simulations were carried out where a
change in CO2 was induced by modulating CO2 production rate in the tissue. The
baseline value for CO2 production rate was modified to be 10% - 200% of baseline
CO2 production after 180 seconds to simulate changes in respiratory demand due
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to metabolic activity. These simulations were performed to test the controller’s
ability to adapt to changes in baseline CO2 production and to observe its ability to
elicit the desired ventilatory pattern to maintain normocapnia. PaCO2 at the end of
the trial would be used to assess the controller’s ability to regulate PaCO2 to
prevent hypocapnia or hypercapnia. The adaptive PG/PS controller was compared
to a version of the controller with a constant PG output, but with adaptable PS,
allowing matching of breath volume profile, but lacking ability to respond to PaCO2.
4.3 Results
4.3.1 Adaptive closed-loop controller responds to changes in metabolic demand
by adapting breath volume and breathing rate in computational studies
Computational studies showed that the controller, when provided with a wide range
of PaCO2 values, can compute a ventilatory pattern with an elevated minute
ventilation, elicit the desired ventilation through modulation of stimulation
parameters, and modulate this ventilation to control the rate of elimination of CO 2
within the body to maintain normocapnia. Figure 13(A) shows that with increasing
PaCO2 in the computational model, the controller responds by increasing tidal
volume and decreasing cycle period.
Simulations were carried out to select a time constant that resulted in a stable
controller response to sudden changes in PaCO2. Controller stability was
assessed by analyzing the responses to a sudden increase in CO2 production and
an apneic event. The results of these simulations using different time constants for
the EMA in the chemoreceptor module are shown in Figure 13(B). After a 50%
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increase in CO2 production in the body tissue compartment, low values of τ led to
a fast response but unstable oscillatory behavior long after the perturbation. Larger
values, however, achieved stability but caused a significant overshoot in PaCO 2
after apnea. Overall, a τ of 8 sec led to a small overshoot with minimal
underdamping as represented by the lowest PaCO2 RMSE.
Simulations compared a fixed-PG version of the controller with one with an
adaptive PG while varying CO2 production rates across a range of 10% to 200%
of the baseline CO2 production rates. The fixed PG controller was only able to
maintain normocapnia within 80% to 110% of the baseline CO 2 production rate,
while the adaptive PG controller was able to achieve normocapnia within a range
of 20% to 180% of the baseline CO2 production rate. Thus, while the PaCO2 did
not always achieve normocapnia, when compared to a version of the controller
with a fixed PG, the adaptive PG/PS showed a much wider range over which CO 2
tissue production rate could vary, as seen in Figure 13(C).
4.3.2 The adaptive PG/PS controller modulated ventilation to reduce etCO2 after
anesthesia-induced hypoventilation
The adaptive closed-loop controller was able to provide pacing that altered
ventilation appropriately thereby alleviating hypercapnia in spinal cord intact
animals that had undergone anesthesia-induced respiratory depression.
Hypoventilation in these animals occurred due to suppression of the ventilatory
response to hypoxia and hypercapnia (Dahan and Teppema, 2003; Sollevi and
Lindahl, 1995). This resulted in a reduction in respiratory rate, as seen in Figure
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14(A), which decreased minute ventilation, resulting in hypercapnia. Figure 14(B)
shows how the adaptive closed-loop controller autonomously altered respiratory
rate and breath volume in response to hypercapnia. Initially, the controller
modulated pacing to increase minute ventilation, which led to a drop in etCO2. As
the trial progressed, the controller adapted and responded to a decrease in etCO 2
values by generating and evoking a ventilatory pattern with reduced minute
ventilation, eventually leading to normocapnia throughout the trial as seen in
Figure 14(C). The PG/PS controller was also able to maintain a low iRMSE
throughout the duration of the trial, showing that the PS module was able to adapt
and closely match the paced breath volume profile to the desired ventilatory
pattern set by the PG module.
Similar results were observed across multiple animals, where the controller was
able to generate and achieve a model-based ventilatory pattern that led to an
overall decrease in etCO2 after ventilatory depression. A summary of the effects of
pacing on etCO2 and iRMSE in all trials for all spinal cord intact animals can be
seen in Figure 14(D) and Figure 14(E). Overall, etCO2 decreased by 1.1% (p <
0.05) from controller initiation to the end of the trial. An average iRMSE of less than
15% also shows that the PS module of the controller was able to adapt despite
variations in desired ventilatory patterns set by the PG module throughout the cycle
as a response to changes in PaCO2. Overall, these trials illustrate that, on a
reduced ventilatory drive due to central respiratory depression, the PG/PS
controller was able to respond appropriately and provide an adequate ventilatory
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pattern. The PG/PS controller was able to elicit and maintain this constantly
updating pattern by continuously modulating stimulation parameters.
4.3.3 The controller reduced and maintained etCO2 close to normocapnic levels
after trauma-induced hypoventilation in spinal cord injured rats
In animals with SCI-induced hypoventilation, the PG/PS controller was also able
to generate and evoke a ventilatory pattern that could normalize PaCO2 as it did
in the anesthesia-induced hypoventilation group. In contrast to the effect of
isoflurane, hemisection at the C2 level of the spinal cord leads to diaphragm
hemiparesis, significantly decreasing inspiratory capacity without affecting the
rCPG response to hypercapnia. This leads to a ventilatory pattern with lower tidal
volume, decreasing overall ventilation which then causes hypercapnia. A
comparison of the ventilatory pattern and ipsilateral diaphragm EMG before and
after left C2 hemisection is shown in Figure 15(A). The EMG trace shows cessation
of ipsilateral diaphragm activity after C2 spinal cord hemisection, verifying
diaphragm hemiparesis. Figure 15(B) shows how the PG/PS controller responded
after controller initiation at the start of the trial, shortly after entrainment onset, and
at the end of the trial. After initiation, the adaptive PG/PS controller is able to elicit
a breath volume profile with a tidal volume similar to or larger than that observed
prior to injury and with a short breath cycle duration. The increase in tidal volume
and decrease in cycle duration led to an increase in minute ventilation which
caused a decrease in etCO2 towards normocapnia. Once etCO2 decreased to
values close to normocapnia, the PG/PS controller updated the desired ventilatory
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pattern to one with a reduced minute ventilation to remain within a normocapnic
range and prevent hypocapnia. Figure 15(C) shows how the controller
continuously updated the ventilatory pattern (as shown by the change in minute
ventilation) throughout the trial in response to etCO2 values while achieving and
maintaining a ventilatory pattern that matched the desired ventilatory profile as
shown by the low iRMSE values (9.1 ± 3.4%).
Figure 15(D) shows average etCO2 for all left C2 spinal cord hemisected animals
after onset of entrainment to pacing and prior to the end of the trial. Across all
animals, the elevated etCO2 resulting from reduced tidal volume decreased
towards normocapnia after the PG/PS controller was turned on (7.1 ± 0.8% to 6.05
± 0.4%). While iRMSE, Figure 15(E), was above that observed in the anesthesiainduced hypoventilation group, controller performance was still deemed
acceptable (17.5 ± 8.2%). This demonstrates that the adaptive controller is still
able to provide adequate respiratory pacing despite differences in body weight and
tidal volume after injury.
4.4 Discussion
The adaptive PG, adaptive PS closed-loop controller for respiratory pacing
developed here was able to maintain adequate arterial CO2 levels despite dynamic
changes in metabolic demand, impaired ventilatory control, and reduced
inspiratory capacity. The adaptive PG/PS controller was able to accomplish this by
implementing a two-stage approach. The controller first generated an adequate
ventilatory pattern in response to PaCO2 through a mathematical model of the
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biological rCPG and then, through the use of an artificial neural network, adapted
stimulation parameters to elicit this desired pattern. This allowed the controller to
both define and elicit a desired ventilatory pattern on a breath-by-breath basis
regardless of metabolic, physiological, or mechanical changes.
A computational testbed was used to test its ability to respond to a dynamic
alteration in PaCO2 prior to in vivo assessment. In simulations, the controller
demonstrated its ability to respond to dynamic changes in PaCO2 levels,
maintained stable performance despite sudden changes in PaCO 2, and proved its
efficiency in maintaining normocapnia in contrast to a version of the controller with
a fixed PG and adaptive PS. In experimental trials, hypoventilation was induced in
two groups of rats, one through anesthesia-induced respiratory depression and
another through reduced inspiratory capacity as a result of diaphragm hemiparesis
caused by left C2 spinal cord hemisection. Both groups showed an overall
decrease in etCO2 towards normocapnia after the adaptive closed-loop controller
was initiated during diaphragmatic pacing. The controller’s ability to respond to
etCO2 on a breath-by-breath basis allowed for an automated physiological-like
response to PaCO2 throughout the trials, restoring normocapnia despite ventilatory
impairments. The results obtained from these studies suggest that the proposed
controller could be used in respiratory pacing applications to restore adequate
ventilatory function and thus maintain normocapnia after hypoventilation
regardless of changes in metabolic demand and biomechanical properties.
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4.4.1 Use of a computational testbed allowed for controller development and
assessment prior to in vivo studies
Prior to in vivo testing, the PG/PS controller was developed through a software-inloop (SIL) approach, allowing for rapid development and assessment of the control
algorithm. A previous implementation of the controller utilized a computational
model of the rat’s ventilatory biomechanics to characterize the PS controller
parameters and assess its behavior (Chapter 3). Aside from decreasing
development time, this SIL approach allowed for the development of the PG/PS
controller in a controlled and predictable environment, particularly for the
development of the chemoreceptor response algorithm. Furthermore, by
simulating the effects of a sudden change in CO2 production and apneic events in
the computational testbed, it was also possible to assess controller behavior and
develop approaches that would minimize their effect on controller stability. This led
to a more robust closed-loop controller that could then be evaluated in an in vivo
setting.
The use of this SIL approach also allows for exploring future changes to the PG/PS
controller that might lead to additional functionality of the PG/PS controller without
having to undergo extensive in vivo assessment. Such functionalities could include
addition of abdominal muscle for control of active expiration. Active expiration
allows for shortening of the cycle period by decreasing expiratory time, thus
increasing minute ventilation. Active expiration could be accomplished by
replacing the rCPG model used here with one that includes active expiration, such
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as that proposed by Molkov et al. (Molkov et al., 2014a). This would require an
additional PS module dedicated to control of abdominal musculature; similar to
how the PG/PS controller approach has been applied for closed-loop
agonist/antagonist muscle control (Fairchild et al., 2010; Kim et al., 2009). A SIL
approach allows for rapid development and implementation of this expiratory
functionality in a convenient and cost-effective environment.
The rCPG model used placed limitations on the range of acceptable CO2
chemoreceptor neural input. This led to the need to impose bounds on the linear
response of the chemoreceptor. This, however, increased safety by limiting the
controller such that apnea or lung damage from excessive tidal volumes did not
occur. Another limitation is that the rCPG model used was based off a cat rCPG,
thus the ventilatory pattern generated did not directly match that found in rats.
However, after scaling of the breath cycle duration to that of rats and through use
of the rat biomechanical model, the ventilatory pattern generated by the controller
was similar enough to be considered adequate for use in the rat model. The rCPG
used was also limited in its functionality in that it was not able to replicate
ventilatory behaviors such as active expiration, sighing, and coughing. While the
current PG/PS controller would not have been able to elicit these behaviors due to
limitations imposed by lack of additional muscle support, future iterations of the
controller could address this issue and extend controller functionality.
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4.4.2 Closed-loop control of PaCO2 achieves and maintains normocapnia after
respiratory depression and after spinal cord injury in vivo
In both sets of animal experiments, the PG/PS controller was able to generate a
desired ventilatory pattern in response to dynamic alterations in PaCO2 levels and
adapt stimulation parameters to elicit this ventilatory pattern, leading to a
ventilatory response similar to that observed physiologically. However, the
resulting ventilatory pattern matched the desired ventilatory pattern more closely
in the anesthesia-induced hypoventilation group than in the hemiparesis-induced
hypoventilation group. In the latter, the reduced inspiratory capacity was not able
to accomplish the elevated tidal volumes generated by the PG after some time
after pacing initiation. This could be attributed to onset of diaphragm fatigue and
reduced contribution from the external intercostal muscles, which would also be
paralyzed after left C2hX. Thus, as reduced tidal volume results in lower minute
ventilation, the rate at which excess CO2 would be removed would also decrease.
Reduced efficacy in CO2 removal could lead to the controller being unable to
achieve normocapnia. This could be addressed through several approaches in
future versions of the controller. Studies have shown that co-activation of
intercostal muscles and diaphragm muscle leads to the production of a breath that
is larger than the additive sum of their individual activations (DiMarco et al., 2005;
Walter et al., 2011). Thus, co-stimulation of these additional muscle sets might be
able to elicit the higher tidal volumes that the PG module generates during elevated
hypercapnia. Furthermore, addition of external intercostal pacing could reduce the
total amount of work required from the diaphragm, reducing the amount of
stimulation received and thus mitigating diaphragm muscle fatigue. Muscle fatigue
could also be mitigated by implementing spinal cord stimulation rather than
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diaphragm or phrenic nerve stimulation. Unlike neuromuscular or neural
stimulation approaches, spinal cord stimulation has shown to elicit physiological
recruitment of muscle fibers (DiMarco and Kowalski, 2013; Hachmann et al., 2017;
Kowalski et al., 2013). By reducing diaphragm fatigue, it might then be possible to
elicit higher tidal volumes than those evoked through other approaches. In
addition, spinal cord stimulation could also synergistically stimulate the external
intercostal muscles (DiMarco and Kowalski, 2013; Hachmann et al., 2017), further
increasing likelihood that elevated tidal volumes could be achieved.
The interplay between an intrinsic neural ventilatory drive and respiratory pacing
becomes much more significant when control of PaCO2 is involved. This was seen
in several trials when the controller was able to reduce etCO 2 to normocapnic
values of 5% or lower. In these cases, loss of entrainment occurred more often
than when etCO2 was above normocapnia. This could be due to the combined
effect of a decrease in respiratory drive leading to lower respiratory rate and
reduced stimulation as a result of reduced desired tidal volume. Studies have
shown that higher respiratory frequencies, within a certain percent difference, are
able to better entrain to mechanical ventilation (Graves et al., 1986; Petrillo and
Glass, 1984). It is likely that the same mechanism is at play here, causing a
decrease in likelihood of entrainment between the intrinsic breathing and the
pacing. As discussed in Chapter 3, reduced stimulation may also lead to increased
rate of loss of entrainment, as entrainment was usually recovered when the
controller increased stimulation. Both aspects can be seen when loss of
entrainment causes a rise in PaCO2. As PaCO2 increases, desired tidal volume
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and respiratory rate increase, strengthening the link between the intrinsic
respiratory drive and increasing likelihood of entrainment. This could be addressed
by modifying the PG module within the rCPG model such that breath volume
remains above a tidal volume conducive to entrainment. By allowing the controller
to create ventilatory patterns with larger tidal volumes and compensating by
decreasing respiratory rate to maintain an equivalent minute ventilation, it would
be possible to elicit ventilation that remains physiologically relevant, but with
improved likelihood of entrainment. Alternatively, it may be possible to improve
entrainment by periodically evoking sighs. The elevated volumes elicited during
sighing would ensure entrainment is maintained. Additionally, sighing has been
shown to improve oxygenation and reduce regional lung strain (Mauri et al., 2015),
thus improving overall patient health.
4.5 Clinical Significance
While mechanical ventilation is the “gold-standard” for ventilatory support,
respiratory pacing has gained traction recently as it is able to overcome many of
the drawbacks of mechanical ventilation such as muscle atrophy due to respiratory
muscle inactivity, lung tissue damage due to excessive pressure, and improved
ambulatory capabilities. However, there is a lack of closed-loop respiratory pacing
paradigms, due in large part to the reasonably extensive safety requirements for
such a life-sustaining technology. The adaptive controller presented here attempts
to deliver a robust and safe control approach for respiratory pacing that does not
rely on subjective measures or clinician expertise to determine appropriate
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stimulation and ventilatory parameters. This adaptive controller is able to control
ventilation to maintain normocapnic PaCO2 in a similar manner as physiological
ventilatory control does. By being able to control ventilation in such a manner, this
controller allows the user to engage in activities that could lead to elevated
metabolic demand, such as during a physically demanding rehabilitation session
after spinal cord injury, without risking hypoventilation. Conversely, it would
prevent hyperventilation under activities that have low metabolic demand, such as
during sleep. By being able to adequately ventilate the user, this controller is likely
to lead to an improvement in the user’s quality of life and overall health.
4.6 Overall conclusion
A closed-loop adaptive controller with a neuromorphic architecture has been
developed through the use of a computational testbed and assessed both
computationally and through in vivo experimentation. The adaptive controller was
able to restore normocapnia in rats with depressed ventilation due to anesthesia
and in rats with reduced inspiratory capacity due to respiratory muscle
hemiparesis. While further optimization is required to increase controller
robustness and reliability prior to clinical use, the work presented here serves as
an important step in the development of a clinically feasible controller for treatment
of chronic hypoventilation.
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Table 1. Controller parameters and computational model constants
r = 1.1

WEI = 1.371

WPI = 1.719

WLI = 5.0

WII = 0.7

WIL = 1.361

WEL = 0.793

WRL = 2.056

WLL = 2.3

WvL = 10.5

WEP = 1.351

WRP = 2.254

WPP = 1.540

WIE = 0.729

WRE = 2.254

WEE = 1.550

WIR = 1.80

WPR = 2.150

WRR = 0.650

WvR = 1.05

K = 0.6

kd = 7 gcm3/s2 mL = 1.8 g

BL = 8.4 g/s

na = 17

np = 6

η = 0.001

T = 0.014 s

VB = 2.28

MT = 0.49

QB = 0.0363 ml/s
τVT = 0.1 s

Q = 1.2875 ml/s

Cin = 0.01

τAT = 0.027 s

τVB = 0.02 s
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KL = 11.5 g/s2
VT = 297.72

QT = 1.2512 ml/s
τAB = 0.01 s

Figures

Figure 11. Architecture and design of the Pattern Generator / Pattern
Shaper adaptive controller. A computational neural network model of the
respiratory central pattern generator generates a ventilatory activity pattern
based on input from pulmonary stretch receptor model and a CO 2 chemotransducer which converts a measure of CO2 into neural drive. The output of the
inspiratory neuronal population serves as input into a biomechanical model of the
chest to provide a “desired” breath volume profile. This desired profile is then
compared to the measured breath volume profile within the Pattern Shaper
module to derive an error measure which is used to modulate output weights in a
single layer artificial neural network with time-shifted activation profiles. The
output of each neuron is summed and serves as input to a programmable
stimulator interfaced with the diaphragm. A change in ventilation due to pacing
then drives a change in CO2, closing the control loop.
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Figure 12. Organization of the computational testbed of the PG/PS
controller using a rat model of chest biomechanics and CO2 dynamics. A
muscle model drives the force generated in a one-dimensional model of chest
biomechanics. The ventilation elicited by this model drives changes in PaCO2 in
the compartmental model of CO2 dynamics. PaCO2 is sampled by the controller
which then drives force generated by the muscle model. Changes in rate of CO 2
production were used to assess the controller’s ability to maintain normocapnia.
Parameters and values have been obtained from literature or scaled to match rat
proportions.
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Figure 13. Adaptive PG/PS controller behavior in a computational testbed.
(A) Open-loop PG, adaptive PS response to increased PaCO2 values. The PG
module generates a desired ventilatory profile (dashed) in response to PaCO 2
levels (dashed). The PS module responds by adapting stimulation to elicit a
breath volume (solid) matching that of the pattern dictated by the PG. (B)
Evaluation of the PG/PS response to PaCO2 under various chemo-transducer
time constants of 2 sec (blue), 8 sec (green), and 30 sec (red). Across all values
assessed (1 – 30 sec), a time constant of 8 sec provided the best stability and
robustness to perturbations. (C) Comparison between a fixed PG adaptive PS
(solid black) and an adaptive PG/PS controller’s (solid grey) ability to maintain
normocapnia from 20% to 200% of the baseline CO2 production rate. The
adaptive PG/PS showed a much wider normocapnic range than the fixed PG
adaptive PS, resulting from the controller’s ability to substantially increase
ventilation in response to PaCO2.
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Figure 14. Adaptive PG/PS controller use in vivo after anesthesia-induced
hypoventilation. (A) Supplemental isoflurane (+1.5%, 100% O2) caused
hypoventilation via a decrease in both tidal volume and respiratory rate after 10
min, which led to an increase in etCO2. (B) Adaptive PG/PS controller response
following ventilatory entrainment, 100 sec, and 900 sec after controller initiation.
The adaptive PG/PS was able to respond to the elevated peak etCO2 (circles) by
eliciting a hypoventilatory pattern (dashed line) and adapting stimulation to match
the measured volume (solid line) to the desired pattern. After 900 sec, etCO2 is
within acceptable levels and thus the ventilatory pattern elicited shows a
decreased tidal volume and respiratory rate. (C) Adaptive PG/PS controller
response throughout a 1000 sec trial. The adaptive PG/PS controller responds to
an elevated etCO2 (orange, empty circle) by dictating a ventilatory pattern with a
high minute ventilation (grey). This in turn causes a decrease in etCO2 towards
normocapnia. Throughout the trial, iRMSE (black, solid circles) remains low
(<10%) showing that the PS controller is able to match the pattern dictated by the
PG. (D) The adaptive PG/PS controller was able to significantly decrease etCO 2
in 6 rats after anesthesia-induced hypoventilation. (E) Across all rats, iRMSE
remained within 20%. One trial showed elevated iRMSE at the end of the trial
due to loss of entrainment. A low tidal volume resulted from low etCO 2,
decreasing likelihood of entrainment.
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Figure 15. Adaptive PG/PS use in vivo after hypoventilation following C2
spinal cord hemisection. (A) Hemisection of the C2 spinal cord leads to
hypoventilation due to paralysis of the hemidiaphragm ipsilateral to the injury as
seen by lack of bursts of EMG activity (black) following C2 spinal hemisection.
This leads to hypoventilation and consequently, to an increase in etCO 2 (empty
circles). (B) The adaptive PG/PS controller initially generates a desired
ventilatory pattern (dashed line) with elevated breath volume and respiratory rate
due to elevated etCO2. The PS then attempts to match the measured volume
(solid line) to the desired ventilatory pattern. At 100 sec, the PS was able to
match the measured breath volume to the elevated ventilatory profile, causing a
decrease from the initial etCO2 (empty circles). By the end of the trial at 800 sec,
etCO2 has been reduced to normocapnic ranges and thus the desired ventilatory
pattern is one with reduced tidal volume and respiratory rate. (C) Throughout the
trial, the PG/PS controller is able to autonomously modulate stimulation
parameters, as shown by the low iRMSE (black, solid circle), to elicit sufficient
minute ventilation (grey) to reduce etCO2 (orange, empty circle) to normocapnic
values. After etCO2 has achieved normocapnia, ventilation is reduced such that
normocapnia is maintained for the rest of the trial. (D) The adaptive PG/PS
controller was able to restore ventilatory function and reduce etCO2 significantly
across all C2 spinal cord hemisected animals. (E) iRMSE across all animals
before and after PG/PS controller intervention.
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CHAPTER 5
ADAPTIVE CONTROL OF VENTILATION THROUGH THE USE OF AN
ADAPTIVE CLOSED-LOOP PATTERN GENERATOR PATTERN SHAPER
CONTROLLER IN AN INTEGRATED HUMAN COMPUTATIONAL TESTBED OF
CHEST BIOMECHANICS AND CO2 DYNAMICS
5.1 Introduction
Currently, respiratory pacing serves as an alternative to mechanical ventilation for
treatment of hypoventilation after spinal injury, in congenital central hypoventilation
syndrome, in central sleep apnea, or other conditions in which the phrenic nerve
and the innervation of the diaphragm are intact, but the respiratory control center
or pathways are impaired. Respiratory pacing electrically stimulates respiratory
muscle(s) or their respective innervating nerves to cause a contraction and thus
elicit a functional breath (DiMarco, 2018; Garara et al., 2016; Onders, 2012). This
prevents issues regarding muscle atrophy, damage due to excessive positive
pressure, and improves mobility and speech (DiMarco, 1999; Onders, 2012).
However, all currently available respiratory pacing systems utilize open-loop
control. Open-loop systems require modulation of stimulation parameters by
trained professionals whenever changes to the ventilatory system occur, such as
changes in CO2 production or onset of fatigue. Additionally, each patient will
possess different muscle activation requirements due to differences in
biomechanical properties such as differences in muscle mass or fiber distribution,
body weight, and pulmonary resistance and compliance. This leads to each patient
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requiring long sessions to calibrate the system and set appropriate stimulation
parameters during their first system setup. Implementation of closed-loop
strategies for respiratory pacing can lead to avoidance of these issues, which may
lead to an improvement in quality of life for users of respiratory pacing systems.
A neuromorphic closed-loop adaptive controller has been developed that can elicit
appropriate ventilation despite changes in CO2 production, respiratory depression,
and presence of diaphragm hemiparesis in rats. This adaptive controller follows a
Pattern Generator Pattern Shaper (PG/PS) approach first developed and
assessed for control of locomotion of the lower limb (Abbas and Chizeck, 1991;
Abbas and Triolo, 1997; Fairchild et al., 2010; Kim et al., 2009; Riess and Abbas,
2000) and then adapted for ventilatory control use as described in Chapters 3 and
Chapters 4 of this dissertation. The PG/PS controller mimics the physiological
control of ventilation by implementation of a PG module that defines a modelbased ventilatory pattern based on a measure of arterial partial pressure of CO 2
(PaCO2) and a PS module that adapts stimulation parameters to elicit a ventilatory
profile that matches the ventilatory profile provided by the PG. This approach leads
to adaptive closed-loop control of ventilation for regulation of PaCO2 regardless of
changes that might occur as a result of biomechanical, physiological, or metabolic
factors.
Previous work concerning the closed-loop adaptive control for respiratory pacing
assessed its performance in computational models and experimental in vivo rat
models. While technology validation in animals is considered a critical step in the
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translational pathway, differences in physiology between human and animal
models can lead to results that differ from those found in preclinical studies (Kwon
et al., 2010; Mak et al., 2014; Siddiqui et al., 2016). Factors such as respiratory
rate range and CO2 dynamics influence how controller parameters are defined and
as such, how it will respond. Hence, a transitional stage is necessary to properly
adapt the controller to match human physiology. Here, a computational testbed
served as a developmental platform in which the controller could be converted for
use in diaphragmatic pacing in people and as a platform to assess the adapted
controller’s performance in comparison to earlier animal studies.
Previously, the adaptive PG/PS controller was developed and assessed in a twostage process. The first stage addressed development and assessment of the PS
module. The PS module was evaluated based on its ability to adapt to achieve and
maintain a desired breath volume regardless of changes in ventilatory
biomechanics. Animal studies were able to demonstrate that the PS module could
adapt stimulation parameters to maintain the desired breath volume, despite onset
of diaphragm muscle fatigue (Siu et al., 2019). Thus, assessment of the controller’s
ability to account for diaphragm fatigue can be considered a viable test to validate
the PS module. The second stage concerned the development and assessment of
the PG module of the adaptive controller as well as its integration with the PS
module. In Chapter 4, the PG/PS controller was evaluated based on its ability to
achieve and maintain normocapnia after hypercapnia had been induced. Studies
in hypercapnic rats showed that the adaptive controller could generate a modelbased ventilatory pattern in response to changes in PaCO2 and elicit this pattern
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through adaptation of the stimulation parameters in order to attain normocapnia.
Thus, assessment of the controller’s response to changes in CO2 production rate,
which would result after changes in metabolic activity, can be used to test the
controller’s ability to respond to changes in metabolic demand. Finally, subject-tosubject variability was inherently present in all animal studies. By evaluating
controller performance in a computational testbed with randomized model
parameter sets, it is possible to demonstrate that the closed-loop PG/PS controller
is able to provide personalized pacing to maintain normocapnia.
A computational testbed with integrated models of ventilatory biomechanics and
CO2 dynamics was used to transition the PG/PS controller to a human
implementation and to carry out the above-mentioned assessments in a
computational environment. These computational studies demonstrated that the
adaptive controller was able to be translated for human implementation in a
manner that preserves or improves the performance observed in previous preclinical trials. While additional validation is required prior to clinical use of this
neuromorphic control algorithm, these computational trials serve to inform future
clinical studies and serve as a platform in which the controller can be optimized to
deliver a safer, more robust adaptive closed-loop controller for respiratory pacing.
5.2 Methods
5.2.1 PG/PS controller design
The PG/PS controller utilizes the architecture similar to that of the human
ventilatory control scheme. This allows the controller to elicit a physiological-like
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ventilatory response. The structure of the PG/PS controller has been defined
previously in Chapter 3 and 4 and will thus only be described briefly here. The PG
consists of a mathematical model based on that of the respiratory central pattern
generator (rCPG) developed by Botros and Bruce (Botros and Bruce, 1990). The
rCPG network model consists of five interconnected neuronal populations that
generate a ventilatory pattern in response to chemoreceptor input and
mechanoreceptor feedback. Each population is maximally activated at a particular
phase of the respiratory cycle. Chemoreceptor and mechanoreceptor inputs
modulate the output of the rCPG. The chemoreceptor input, nCO2, is given by a
linear stepwise function of PaCO2 given below.

𝑛𝐶𝑂2

𝑃𝑎 𝐶𝑂2 < 35
𝑛𝐶𝑂2 = 0.2
= {53 < 𝑃𝑎 𝐶𝑂2 < 35 𝑛𝐶𝑂2 = (𝑃𝑎𝐶𝑂2 ∙ 0.072) − 2.32
𝑃𝑎 𝐶𝑂2 > 53
𝑛𝐶𝑂2 = 1.5

(23)

To represent the mechanoreceptor input, a one-dimensional model of chest
biomechanics was used (Milhorn, 1966). The output from the “inspiratory” neuronal
population of the rCPG drives the diaphragm muscle within the biomechanical
model, creating a contractile force which drives diaphragm displacement. This
displacement is then scaled to average human parameters to represent breath
volume. This output contains information on the timing and shape of the breath as
dictated by the PG and the biomechanical model and serves as the “desired”
ventilatory pattern that the PS module described below is set to follow. The PG
continuously generates a ventilatory pattern in response to alterations in PaCO2
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values, updating the desired ventilatory pattern used by the PS module within
breaths.
The PS module’s role is to adapt stimulation parameters to evoke the ventilatory
pattern generated by the PG module. The PS module is composed of a singlelayer neural network with neuronal outputs shifted by 0.05 s along the respiratory
cycle, as described in Chapter 3 (Siu et al., 2019) and Chapter 4. Distribution of
the neurons across the respiratory cycle allows for activation of specific neurons
during specific respiratory phases. The total number of neurons within the network
is based off a maximal breath duration of 6 seconds, resulting in a total of 120
artificial neurons. Shortening of the breathing cycle inactivates neurons that are
active during the early expiratory phase of the breathing cycle. Neurons found
elsewhere in the cycle remain active to ensure they can contribute to the controller
output during elevated respiratory rates. Briefly, each neuronal output, or
activation, consists of a weighted raised cosine function maximal at equally
distributed discrete points throughout the breath cycle. At each time step, weights
for each neuronal output is continuously modulated based on an error value, a
learning rate, and previous neuronal outputs. The error is calculated from
differences between the desired volume profile and the evoked volume at each
time step. A learning rate value increases or decreases the magnitude by which
the weights are updated. Previous activations, up to a certain past activation value,
are averaged to distribute the error of previous activations into the current
activation to account for biomechanical delays in muscle activation. The controller
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parameters are given in Table 1. Figure 16 depicts a PG/PS controller design and
its integration with the computational testbed described below.
5.2.2 Computational testbed for controller development
The PG/PS controller was developed and tested in Simulink (Mathworks Inc., MA)
using a computational model of the human respiratory biomechanics paired with a
reverse recruitment model of the diaphragm (Hillen et al., 2014), and a CO2
compartmental model (Batzel and Tran, 2000).
The biomechanical model consists of a Hill-type muscle model with reverse
recruitment behavior, chest resistance and compliance, and a pulley system
representing diaphragm and central tendon mechanics (Hillen et al., 2014). The
muscle model implemented here has been described previously (Cheng et al.,
2000; Song et al., 2008) and adapted to the diaphragm muscle using parameters
reported elsewhere (Gorman et al., 2002). Here, the muscle is divided into two
hemidiaphragms,

with

identical

stimulation

being

delivered

to

both

hemidiaphragms. The biomechanical model is represented by the mathematical
model listed below,
𝐹𝐿ℎ𝑑𝑖𝑎 + 𝐹𝑅ℎ𝑑𝑖𝑎 = 𝐵𝐿2 𝑥̇ + 𝐾𝐿2 𝑥

(24)

With FLhdia and FRhdia representing the force elicited by the left and right
hemidiaphragms, respectively. The PG/PS controller is paired with this
biomechanical model by replacing the neural activation with the controller output.
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The CO2 2-compartment model is based off a model developed for analysis of
respiratory dynamics (Batzel and Tran, 2000). This adapted model consists of a
lung compartment in which transport of CO2 between ambient air and blood
occurs, and a tissue model in which blood collects the CO2 produced by a tissue
volume. The original model also consists of a brain compartment for CO2 feedback
to a central controller; however, that aspect was ignored in the current
implementation as the adaptive controller is to serve as a substitute for the intrinsic
central controller. Production of CO2 within the tissue compartment is used to
represent overall CO2 production in the body.
Concentration of CO2 in the lung compartment is defined by
̇
𝑉𝐴,𝐶𝑂2 𝐹𝐴,𝐶𝑂
= 𝑄(𝐶𝑣,𝐶𝑂2 − 𝐶𝑎,𝐶𝑂2 ) + 𝑉𝐴̇ (𝐹𝑖,𝐶𝑂2 − 𝐹𝐴,𝐶𝑂2 )
2

(25)

Where FA, CO2 and Fi, CO2 represent the fractional concentration of CO2 in the alveoli
and inspired air, respectively. Effective CO2 volume in the lung compartment is
given by VA,CO2. CV,CO2 and Ca,CO2, refer to concentration of CO2 in venous blood
and arterial blood respectively. Q refers to cardiac output, or pulmonary flow, and
VA refers to alveolar ventilation, which is provided by the biomechanical model
controlled by the PG/PS controller.
The tissue compartment where CO2 is produced is given by
̇
𝑉𝑇,𝐶𝑂2 𝐶𝑣,𝐶𝑂
= 𝑄(𝐶𝑎,𝐶𝑂2 − 𝐶𝑣,𝐶𝑂2 ) + 𝑀𝑅𝐶𝑂2
2

(26)

Where VT,CO2 is the volume of the tissue in which CO2 is produced, Cv,CO2 is the
venous concentration of CO2, Ca,CO2 is the arterial CO2 concentration, and MRCO2
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is the rate at which CO2 is produced. The transport delays this CO2 compartmental
model and other constants can be found in Table 1.
5.2.3 Simulations
The controller was integrated into the Simulink computational testbed by utilizing
PaCO2 output from the CO2 compartmental model as the input to the PG and using
the biomechanical model output as the measured volume input to the PS module.
A scheme of this computational setup is shown in Figure 17. Simulations were
done to assess the adaptive controller’s performance when presented with
changes in production rate of CO2, in the presence of severe fatigue, and on
models with randomized biomechanical properties. Performance in all of these
simulations was assessed by deviation of PaCO2 from the normocapnic range to
assess ability to control PaCO2 and by evaluation of iRMSE values across the
simulation to assess ability to match the elicited ventilatory pattern to the desired
ventilatory pattern.
Simulations in which CO2 production rate was varied from 20% to 200% of the
baseline CO2 production rate to represent changes in metabolic activity were
carried out to assess the controller’s ability to maintain PaCO2 levels within
normocapnic range. The PG/PS controller was initiated at t = 0 and left to perform
under a nominal CO2 production rate for 500 sec, after which the change in CO 2
production occurred. These simulations were designed to determine the range
over which normocapnia can be maintained by the PG/PS controller. For
comparison, the same set of simulations were carried out utilizing a version of the
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controller with an open-loop PG that is unable to respond to PaCO2 and thus
maintains a constant ventilatory pattern throughout the simulated trials.
To assess the controller’s ability to account for fatigue, changes in fiber properties
were made to the muscle model (Hillen et al., 2014). The non-fatigued model had
a fractional physiological cross area (PCSA) of 0.37 for slow fibers and 0.63 for
fast fatigable fibers (Polla et al., 2004; Stubbings et al., 2008). In the fatigued
model, the fractional PCSA was changed to 0.99 for slow fibers and 0.01 for fast
fatigable fibers to represent the shift in the ratio of fiber contribution to force
production after onset of fatigue. Moreover, muscle mass was reduced from 213 g
to 150 g to simulate a 50% reduction in force after fatigue to match experimental
data (Gorman et al., 2002). Simulations consisted of trials under both non-fatigued
and fatigued conditions. Changes in iRMSE and charge delivered were assessed
to observe how the controller responded to these fatigue-related changes.
Lastly, to assess the PG/PS controller’s ability to deliver personalized pacing to
achieve and maintain normocapnia, simulations with randomized model
parameters within the computational testbed of human ventilatory biomechanics
and CO2 dynamics were carried out. The parameters that were changed were
diaphragm muscle mass, chest compliance, effective CO2 volume within the lungs,
cardiac output, and volume of tissue in which CO2 is produced. These parameters
were randomized following a normal distribution to values within 20% of the
normative values found in Table 1. A total of five randomized sets of parameters
were used. The model parameters used in each testbed are listed in Table 2. Each
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trial consisted of a 50% increase in CO2 production rate after 500 sec of controller
initiation.
5.3 Results
5.3.1 The adaptive PG/PS controller is capable of maintaining normocapnia after
changes in CO2 production rate
The adaptive PG/PS controller was able to determine a proper ventilatory pattern
based on the change in CO2 production, modulate stimulation parameters to match
and maintain this ventilatory pattern, and then elicit a proper response again when
CO2 production rate returned to baseline. This response can be seen in Figure
18(A) across different time periods in a simulated trial lasting 2000 sec. As PaCO2
increased due to a 40% increase in CO2 production rate, the PG responded by
eliciting a new ventilatory profile with a higher minute ventilation, transitioning from
one of 119.1 L/min to 135.05 L/min. This increase in minute ventilation was
sufficient to maintain PaCO2 within normocapnic levels. Despite the PG generating
different ventilatory profiles as it responded to changes in PaCO 2, the PS module
was able to fine-tune stimulation parameters to elicit a ventilatory profile that
matched that of the desired ventilatory profile. Figure 18(B) depicts the same trial
as in Figure 18(A) but shows PaCO2 and iRMSE throughout the entirety of the trial.
CO2 production rate was increased by 40% at 500 sec and remained elevated for
the remaining duration of the trial. Throughout the trial, iRMSE was consistently
low, showing that the PG/PS controller was able to match the desired ventilatory
profile consistently as seen in Figure 18(A). Additionally, it is worth highlighting that
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the rate of change in PaCO2 due to change in CO2 production was slower than the
rate of change in PaCO2 due to ventilation, allowing for an adequately damped
response to changes in PaCO2, reducing risk of instability and/or oscillatory
behavior.
Figure 18(C) compares PaCO2 between the fixed PG, adaptive PS and the fully
adaptive PG/PS controllers at the end of trials in which CO2 production rate was
varied from 20% to 200% of the baseline rate. The adaptive PG/PS controller was
able to maintain normocapnia within a range of 20% to 180% of the baseline rate
of CO2 production. This is a much wider range when compared to when a fixed
PG, adaptive PS controller is used (90 to 110% of baseline). Figure 18(D) shows
PaCO2 and minute ventilation in trials where CO2 production rate was altered to
20%, and 180% of the baseline rate using both a fixed PG, adaptive PS and an
adaptive PG/PS approach. The adaptive PG/PS controller has a clear effect on
PaCO2 as it is able to significantly reduce the effects of the change in CO 2
production rate.
5.3.2 The adaptive controller is able to adapt to account for fatigue
The presence of muscle fatigue did not adversely affect the controller’s ability to
elicit a desired ventilatory pattern to achieve and maintain normocapnia. Figure
19(A) and Figure 19(B) show the first 40 sec of trials in which, respectively, no
fatigue is present and with fatigue. During fatigue, a markedly larger PG/PS
controller output amplitude is observed. This is caused by the reduced force
capacity of the muscle, prompting the adaptive PS to provide a compensatory
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increase in output to elicit a ventilatory pattern that matches the desired ventilatory
profile given by the PG.
Figure 19(C) shows that here was no difference in iRMSE between both
conditions, inferring that the controller was able to achieve the desired ventilatory
profile regardless of fatigue. However, as expected, peak controller output differed
greatly as the trial with fatigue showed a large increase in output to account for the
reduced force capacity of the diaphragm. The resulting PG/PS output profile in
both trials shows how differences in muscle condition can lead to differences in
controller output. Figure 19(D) shows the PG/PS controller output profile of the last
cycle of each trial. Other than an elevated amplitude, differences in the controller
output profile are present. This is most likely due to differences in activation
properties as a result of difference in fiber fractional PCSA rather than differences
in force capacity. This highlights the benefits of implementing a controller that is
able to autonomously decide the stimulation parameters in a closed-loop manner
to account for changes in muscle fiber properties as a result of muscle fatigue or
muscle atrophy.
5.3.3 The PG/PS controller is capable of providing individualized respiratory pacing
to achieve and maintain adequate ventilation
All previous simulations assessed controller response in a single computational
model with the same model parameters. To verify that the PG/PS controller is able
to achieve the normocapnia regardless of differences in individual properties, the
controller was implemented in computational testbeds of human ventilatory
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biomechanics and CO2 dynamics with randomized model parameters. Regardless
of these differences, the controller was able to modulate stimulation to match the
ventilatory pattern given by the PG module of the controller, resulting in
normocapnic PaCO2 (Figure 20(A)) and low iRMSE (Figure 20(B)). While iRMSE
and PaCO2 were very similar for all sets of parameters, there were expected
differences found in the PG/PS controller output. Figure 20(C) shows that PG/PS
controller output per cycle differed more between each set of parameters
compared to iRMSE and PaCO2. This can be attributed to the PG/PS controller
being able to account for differences in biomechanical properties between the
parameter sets resulting in differences in PG/PS controller output profiles.
5.4 Discussion
A human computational model served as a testbed to evaluate performance of an
adaptive closed-loop controller for ventilatory control after transition from a rat
model implementation. This adaptive controller was able to respond to a measure
of PaCO2, determine an appropriate ventilatory response, and adapt stimulation to
elicit this response, successfully mimicking physiological control of PaCO2 in a
human computational model of ventilatory biomechanics and CO 2 dynamics.
Simulations showed that the adaptive controller was able to adequately control
PaCO2 to maintain normocapnia within a wide range of CO2 production rates,
despite presence of fatigue, and when varying model parameters in the
computational testbed. This computational study serves as an important transition
between pre-clinical studies and future clinical trials, addressing some of the
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questions and concerns that would be present during clinical implementation of the
closed-loop adaptive controller.
5.4.1 The adaptive controller is able to determine an appropriate ventilatory
response to maintain normocapnia
The PG/PS adaptive controller is designed to respond to changes in PaCO 2
continuously to ensure normocapnia is maintained. However, similarly to
physiological ventilatory control, the PG/PS controller is only able to maintain
normocapnia within a certain range. In the simulations carried out, normocapnia
was not maintained when the CO2 production rate was less than 20% and more
than 180% of the baseline value, respectively leading to slight hypocapnia and
hypercapnia, respectively. However, when a controller unable to account for
PaCO2 was assessed at these limits, the resulting values were those that suggest
cerebral damage (Marhong and Fan, 2014; Roussos and Koutsoukou, 2003),
demonstrating the advantage of the adaptive closed-loop control approach over
an open-loop control approach. It is, however, possible to further optimize the
controller to expand this range. While the inspiratory breath volume elicited by the
PG did approach the suggested inspiratory capacity for adult males, respiratory
rate could still be maximized by reducing expiratory time through active expiration.
This could be accomplished through control of expiratory muscles and by replacing
the current rCPG model used to one that exhibits active expiration, such as one
proposed by Molkov et al (Molkov et al., 2014a). A separate PS module would
need to be included to control the additional expiratory muscles in a similar manner
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as shown in earlier studies concerning flexor/extensor muscle PG/PS control
(Abbas and Triolo, 1997; Fairchild et al., 2010; Jung et al., 2009; Kim et al., 2009).
Instead of activating off the inspiratory neuronal population, this additional PS
module would be based off the expiratory neuronal population; providing the
desired activation for the abdominal muscles.
While the ventilatory pattern provided by the PG was limited due to physiological
constraints, the ventilatory changes elicited by the controller were comparable to
physiological limits. Hence, it is possible that metabolic conditions leading to a rate
of CO2 production that exceeds that of CO2 removal would be due to more critical
and severe issues that are beyond the capabilities of the PG/PS controller.
However, for conditions where CO2 production remains within the limits of the
controller, such as during increased physical activity or sleep, the PG/PS controller
presented here can provide sufficient ventilatory control to maintain normocapnia.
5.4.2 The adaptive controller adapts stimulation to account for onset of musclerelated changes
Electrical stimulation of skeletal muscle has been shown to increase onset of
muscle fatigue (Ratkevičius et al., 1998). This is mostly due to fast fatigable fibers
being activated at lower current amplitudes than the slow fatigue-resistant fibers,
causing reverse recruitment of muscle fiber types (Peckham and Knutson, 2005).
As the fatigable fibers are recruited more often than usual, onset of muscle fatigue
occurs. Recruitment of additional fatigue resistant fibers is then required to account
for the loss of the fatigable fibers if the same amount of force is required to be
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produced by the muscle. This would translate to a wider current spread, which can
be accomplished by increasing stimulation amplitude. Simulations assessing
PG/PS controller performance under a fatigued state showed that the controller
was able to elicit the desired ventilatory pattern by autonomously increasing
amplitude of the stimulation delivered, leading to a wider current spread, recruiting
more fibers and thus increasing force generated.
The diaphragm muscle has a relatively even distribution of fatigue-resistant and
fatigable fibers compared to other skeletal muscles (Polla et al., 2004; Stubbings
et al., 2008). During eupnic breathing, slow fatigue-resistant fibers are mostly
active, with the fast-fatigable fibers being active during behaviors requiring a
stronger contractile force such as sighing, coughing, and sneezing (Seven et al.,
2014). Since these fast-fatigable fibers elicit a strong contractile force with low
stimulation, the stimulation profile required to elicit a eupneic breath is low in
amplitude and narrow. Meanwhile, during fatigue, when these fatigable fibers are
exhausted, the stimulation waveform required is one that shows a ramping
increase in amplitude to recruit more fibers, leading to a longer lasting stimulation
profile with a higher peak amplitude. The PG/PS controller is able to autonomously
modulate stimulation shape which resulted in stimulation waveforms with these
characteristics, suggesting that it has the ability to overcome the effects of fatigue
to maintain a desired ventilatory pattern.
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5.4.3 Individualized pacing for respiratory rehabilitation
One of the benefits of a closed-loop approach to respiratory pacing is that the
adaptive controller can figure out how best to achieve a desired ventilatory pattern
regardless of the state or properties of respiratory biomechanics. This is a critical
function of the controller, particularly for clinical implementation, as between
subject variations are bound to be present. Simulations showed that, despite
randomized differences in muscle mass, chest compliance, and chest resistance,
the controller was still able to modulate stimulation to achieve the desired
ventilatory pattern. This suggests that the controller will be able to adapt to
individualized pacing in a clinical setting regardless of disease or conditions
affecting chest biomechanics.
These simulations also highlighted how the controller can account for effects of
muscle condition on ventilatory mechanics. This is clinically relevant as most
chronically ventilated individuals will display some degree of diaphragm muscle
atrophy. The reduced muscle mass due to atrophy severely limits the contractile
force capacity of the diaphragm, reducing inspiratory capacity. When encountering
these situations, the controller would increase stimulation to increase muscle
recruitment and thus elicit sufficient force to produce adequate breath volume. If
the PG/PS controller is used chronically or periodically, recovery from atrophy may
occur due to activation of muscle fibers (Ayas et al., 1999). This would lead to
progressive increments in intrinsic muscle force, which the controller would
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account for by reducing stimulation required to elicit a breath, leading to eventual
weaning from respiratory pacing in an autonomous manner.
Respiratory pacing has been used in respiratory rehabilitation following cervical
spinal cord injury to restore ventilatory independence. Currently, before
dependence on pacing, patients with implanted respiratory pacers must undergo
a conditioning period to increase the diaphragm muscle’s resistance to stimulationinduced fatigue (Glenn et al., 1984; Pavlovic and Wendt, 2003). During this period,
mechanical ventilation is still used to support ventilation, which may attenuate the
beneficial effects of the pacing sessions. The structure of the PG/PS controller is
such that it is possible to create a synergistic effect with mechanical ventilation to
overcome these limitations. If the PG module is set such that it follows the
respiratory frequency of the mechanical ventilator and the mechanical ventilator is
set to provide a substantial fraction of the desired breath volume, the PS module
would be able to adapt in order to provide only the stimulation required to achieve
the remaining fraction of the desired breath volume. This approach would likely
reduce the time required for diaphragm conditioning as the pacing would be
continuous, rather than intermittent, and also minimize the risk of hypoventilation
as mechanical ventilation is still present.
In the current study, each of the assessments was performed exclusive to one
another. However, in clinical implementation, all the simulated conditions are likely
to be encountered within individual patients. Future computational studies that
explore the interactions between these parameters in more detail are suggested.
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These studies would help define the patient demographic that most likely will
respond positively to adaptive pacing, improving patient outcomes and reducing
risk to those that do not fall within this demographic. Furthermore, other situations
likely to be encountered clinically could also be explored. Among these are
presence of muscle atrophy, response to diaphragm pacing conditioning,
interaction with residual muscle activity, and effect of postural load.
The work presented here aims to not only serve as a step for use of the adaptive
PG/PS controller clinically, but also to serve as one example of use of
computational modeling to support clinical assessment of new control algorithms
beyond what is possible clinically. With the development of clinically relevant
models and increase in computational power and availability, the feasibility of
implementing these computational testbeds for development and assessment of
control schemes is magnified. This can lead to a reduction in time across all the
translational steps of new technology, from development to approval for clinical
use. While pre-clinical and clinical trials are still required to account for factors not
included in the computational models, computational clinical assessment can still
serve an important role.
Here, a computational testbed of human ventilatory biomechanics and CO2
dynamics has been implemented to assess the performance of an adaptive closedloop controller for respiratory pacing under the presence of clinically relevant
conditions. Results indicate that the adaptive controller is able to elicit a ventilatory
profile capable of achieving and/or maintaining normocapnia regardless of any of
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the conditions assessed in a testbed based on human biomechanics and CO 2
dynamics. This serves as an important step towards clinical assessment of the
adaptive PG/PS controller. Furthermore, implementation of a computational
testbed allows for the development, optimization, and implementation of new
controller features without requiring extensive pre-clinical assessment, reducing
time spent in the development cycle; thus, delivering essential technology to
market and users at a faster pace.
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Tables
Table 1. Adaptive PG/PS controller parameters and computational model constants

aE = 1.409

aI = 3.091

WEI = 1.371

WPI = 1.719

WEL = 0.793

aP = 0.7

aR = 0.591

WLI = 2.5

WII = 0.85

WIL = 1.361

WRL = 2.056

WPL = 6.0

WLL = 1.15

WvL = 10.5

WEP = 1.351

WRP = 2.254

WPP = 1.540

WIE = 0.729

WRE = 2.25

WEE = 1.550

WIR = 1.80

WPR = 2.150

WRR = 0.650

WvR = 1.05

BE = 4.14
K = 0.6
Kbm = 3500 g/s2
np = 30
VCO2 = 3.2 L

BI = 5.044
mbm = 600 g

aL = 1.568

BL = -2.2

BP = 3.989

kbm = 2.8x106 gcm3/s2

Bdia = 250 g/s

BR = 2.193

Bbm = 2800 g/s

mdia = 312 g

na = 15

T = 0.05 s

VT = 15 L

MCO2 = 3.667

Q = 100 ml/s τLT = 19.8 s

τTL= 4.6 s

η = 0.0001
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Table 2. Parameter sets used to assess controller performance computationally
with different ventilatory biomechanics and CO2 dynamics.

Testbed

Cardiac

Effective

output

CO2 volume

Muscle

Compliance

Tissue

mass (g)

(g/s)

volume (ml)

(ml/s)

(ml)

1

110.3

3511.2

203.8

265.5

13027.1

2

108.2

2600.7

194.0

204.6

12582.8

3

112.9

3449.4

197.4

295.0

12206.7

4

97.6

3048.4

235.6

279.5

13121.2

5

99.6

3130.4

225.5

270.9

16528.1
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Figures

Figure 16. Architecture and design of the Pattern Generator / Pattern
Shaper adaptive controller for use in computational human studies for
control of PaCO2. A modeled CO2 chemoreceptor converts PaCO2 into neural
drive which serves as an input to a model of the respiratory central pattern
generator neural network. The Patten Generator output is used in a
biomechanical model of the chest to determine a “desired” breath volume profile.
This volume profile is compared against the measured breath volume throughout
the respiratory cycle within the Pattern Shaper. The derived error drives changes
in neuronal weights in an artificial neural network. The summation of the
weighted neuronal outputs serves as the controller output which then dictates
stimulation delivered to the diaphragm muscle model. A change in ventilation due
to pacing then drives a change in PaCO2, closing the control loop.
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Figure 17. Organization of the computational testbed of the PG/PS
controller using a human model of chest biomechanics and CO2 dynamics.
A Hill-type muscle model drives the force generated in a one-dimensional model
of chest biomechanics. Displacement caused by force is linearly transformed to
breath volume. The ventilation elicited affects PaCO2 concentration in a
compartmental model of CO2 dynamics. The controller generates a ventilatory
pattern based on PaCO2 sampled and adapts to match this pattern via
stimulation of the diaphragm. Changes in CO2 production rate were used to
assess controller’s ability to maintain normocapnia.
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Figure 18. Adaptive PG/PS controller effect on PaCO2 after changes in CO2
production rates. (A) Example of a simulated trial showing the ventilatory
pattern generated by the adaptive PG/PS controller (dashed) in response to
changes in PaCO2 (dotted) and its ability to match the elicited breath volume
(solid, grey) to this pattern early in the trial, 150 sec after increasing CO2
production rate, and shortly before end of trial. (B) PaCO2 (black) and iRMSE
(grey) throughout the 2000 sec trial in which CO2 was increased by 40% at 500
sec. The pale blue shaded region indicates normocapnia (35 – 45 mmHg). (C)
Comparison of final PaCO2 levels between a fixed PG, adaptive PS controller
(dotted) and an adaptive PG/PS controller (solid) in trials where CO 2 production
was varied from 20% to 200% of the baseline production rate. (D) The adaptive
PG/PS controller is able to maintain PaCO2 levels within a normocapnic range in
trials in which the rate of CO2 produced due to metabolic processes was reduced
to 20% of baseline (grey) or increased to 180% of baseline (black) using a fixed
PG, adaptive PS controller (dashed) and an adaptive PG/PS controller (solid).
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Figure 19. Adaptive PG/PS controller response in a non-fatigued and
fatigued diaphragm muscle. (A) Measured breath volume (solid), desired
breath volume (dashed), and PG/PS controller output (dotted) in a trial in a nonfatigued diaphragm muscle compared to (B) a trial in which the diaphragm
muscle exhibits severe muscular fatigue. (C) PG/PS controller output (black) and
iRMSE (blue) in a non-fatigued diaphragm (solid) and a fatigued diaphragm
(dashed) during the initial 100 sec of the trials. (D) PG/PS controller output profile
in a non-fatigued diaphragm (solid) and a fatigued diaphragm (dashed) 2000 sec
after controller initiation.
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Figure 20. Adaptive PG/PS controller performance across multiple sets of
randomized testbed parameters after a 50% increase in CO2 production.
Each color represents a different testbed. (A) After increasing CO2 production by
50% at 500 sec, PaCO2 was able to remain within normocapnia for all testbeds.
Pale blue shaded region depicts normocapnic range. (B) A low iRMSE for all
testbeds indicated that the PG/PS controller was able to finely modulate
controller output to achieve the desired ventilatory profile. (C) PG/PS controller
output per cycle, analogous to charge per cycle, varied between testbeds to
account for differences in the biomechanical properties of each testbed.
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CHAPTER 6
DISSERTATION CONCLUSIONS
6.1 Summary
An adaptive closed-loop control system for ventilatory support through respiratory
pacing of the diaphragm has been developed and assessed. This control system
follows a pattern generator/pattern shaper architecture, where a mathematical
model of the respiratory central pattern generator (rCPG) neural network responds
to a measure of PaCO2 by generating an adequate model-based ventilatory
pattern while a single-layer adaptive neural network with error driven neuronal
weights define the stimulation amplitude throughout the duration of the respiratory
cycle. The PG/PS design leads to breath-by-breath feedforward control of PaCO2
and within breath feedback control of stimulation to achieve a desired breath
volume profile. This allows for the controller to maintain ventilation regardless of
changes to CO2 production, ventilatory biomechanics, muscle activation
properties, or tissue-electrode interface conditions.
The PG/PS respiratory control system was assessed computationally and
experimentally. Computational models of both rat and human respiratory
mechanics and CO2 dynamics served as testbeds for controller development and
characterization prior to in vivo implementation. Animal experiments in spinal cordintact rats and spinal cord hemisected animals permitted assessment of the
Pattern Shaper in a complex biological setting. Two models of hypoventilation,
respiratory depression due to anesthesia and reduced inspiratory capacity due to
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respiratory muscle hemiparesis, were used for assessment of the PG/PS system’s
ability to control PaCO2. Both the computational and experimental studies showed
that the controller is able to respond adequately to PaCO2 by generating an
appropriate ventilatory response and by modulating stimulation to achieve this
desired ventilatory pattern to normalize PaCO2 levels.
6.2 Conclusions
The following conclusions on the performance and abilities of the PG/PS
respiratory control system have been drawn based on the research presented in
the previous chapters.
•

The Pattern Shaper was able to autonomously adapt to determine
stimulation parameters that could evoke and maintain a desired breath
volume profile. Adaptation to the difference between the evoked breath
volume and the desired breath volume allowed the controller to adapt to the
subject’s biomechanics, providing personalized pacing to achieve the
desired breath volume profile without the need for an extensive calibration
process. Once the desired breath profile was achieved, the controller was
able to maintain it through continuous adaptation despite changes that
might affect the stimulation’s ability to achieve the desired breath volume
profile, such as muscle fatigue. Furthermore, it is possible for the Pattern
Shaper to serve as an approach for automatic weaning from respiratory
pacing. As the intrinsic diaphragm contribution to breath volume increases
as a result of recovery, a positive error would occur. The controller would

135

compensate for this by decreasing stimulation. As this gradual change
occurs, stimulation would gradually decrease until it ceases when the
diaphragm is able to elicit a breath without assistance. This would effectively
wean the patient from assisted ventilation without the need for clinician
intervention.
•

The implementation of the Pattern Generator showed that it is possible to
dynamically modulate cycle duration and breath volume in response to
PaCO2 while adapting stimulation parameters through the Pattern Shaper
to elicit this ventilatory pattern. The Pattern Generator mimics the
physiological ventilatory response by generating a model-based ventilatory
pattern in response to dynamic PaCO2 levels. The resulting response then
serves as the ventilatory profile that the Pattern Shaper attempts to attain
by adapting stimulation. By responding to PaCO2 in a physiological-like
manner, the PG/PS respiratory control system could allow users to enjoy
activities that increase or decrease metabolic demand without fear of
inadequate ventilation. This has implications in daily life as well as during
rehabilitation, where physically intensive activities that may not have been
possible otherwise may lead to improved recovery outcomes.

•

The PG/PS respiratory pacing controller was able to elicit appropriate
ventilation to maintain normocapnia in an integrated model of human
ventilatory biomechanics and CO2 dynamics in multiple clinically-relevant
scenarios. After adaptation for human use, the PG/PS controller was able
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to achieve and/or maintain normocapnia under conditions where CO2
production increased due to increased metabolic demand, after severe
diaphragm muscle fatigue, and when implemented in testbeds with different
model parameters. These simulated trials represent conditions that are
likely to be found during chronic clinical use and thus serve as preliminary
proof that the controller is a viable approach for control of respiratory pacing.
These computational studies thus serve to further the development of the
controller and to advance the translational pathway for future clinical
studies.
The Pattern Shaper proved to be a viable strategy for control of diaphragmatic
contraction for respiratory support thanks to its ability to adapt stimulation to
provide complementary electrical activation of the diaphragm. In the presence of
residual ventilatory function, the controller was able to modulate stimulation such
that the summation of the intrinsic and electrical activation of the diaphragm
muscle led to the matching of the desired ventilatory pattern, delivering only the
necessary amount of charge. As changes in the intrinsic contractile force
generated by the diaphragm occurred, likely due to muscle fatigue, the PS was
able to compensate by increasing stimulation delivered and thus was able to
achieve and maintain the desired breath volume profile. This implies that other
changes that affect muscle force may also be able to be accounted for, such as
changes due to atrophy or hypertrophy of the diaphragm. One of the benefits of an
adaptive closed-loop approach to respiratory pacing is that the adaptive controller
can figure out how best to achieve a desired ventilatory pattern regardless of the
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state or properties of respiratory biomechanics. This is a critical function of the
controller, particularly for clinical implementation, as between subject variations
are bound to be present.
Implementation of this neuromorphic respiratory control system shows that it is
possible to control an autonomic biological function while also adapting to residual
function. Intrinsic ventilatory function is present in both spinal cord intact and C2
spinal cord hemisected rats, albeit reduced in the latter. This requires entrainment
between the intrinsic respiratory drive and the PG/PS respiratory control system
for proper adaptation and modulation of stimulation parameters. The PG/PS
controller was able to establish a link with the biological rCPG to achieve
respiratory entrainment, likely through vagal pathways. Additionally, when loss of
entrainment occurred, the PG/PS controller’s intrinsic characteristics increased
stimulation delivered. This led to re-establishing of intrinsic ventilation entrainment
to the pacing. By properly taking advantage of the interaction between the intrinsic
biological control and the neurostimulation pacing technology, it may be possible
to develop control strategies that are able to not only restore function of other
autonomic processes but also improve their existing function. These may include
control of visceral organ function, such as gastrointestinal control to improve
motility or control of spleen function for modulation of autoimmune function.
The development of a closed-loop control strategy for the respiratory system is
significant in that it may allow for more extensive use of respiratory pacing, leading
to improved clinical outcomes for the system’s users. The control system’s ability
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to determine an adequate ventilatory pattern and modulate stimulation to match
the given ventilatory pattern ensures that the patient will maintain normocapnia
without the need for constant supervision or manipulation of controller and/or
stimulation parameters.
6.3 Limitations
While the work presented here showed adequate PG/PS controller performance,
all control applications rely heavily on the accuracy and precision of the input
signals to the controller. Currently, a robust and reliable method for continuous
PaCO2 sensing is not available for clinical use. While end-tidal CO2 measurement
is common in hospital settings, it is not a reliable measure of PaCO2 as its accuracy
can be severely impacted by respiratory disorders, cardiac disorders, and any
other factor affecting the ventilation/perfusion relationship (Huttmann et al., 2014).
Other approaches for continuous PaCO2 monitoring are available, such as
transcutaneous CO2 sensors, but these require continuous application of heat to
improve transcutaneous CO2 diffusion and reconditioning of the electrode after
several hours (Janssens et al., 1998). These factors prevent transcutaneous CO2
sensing from being a reliable chronic approach to PaCO2 sensing. Similarly,
wearable breath volume sensing approaches have been developed for respiratory
monitoring (Caretti et al., 1994; Lonbe et al., 1999; Wolf and Arnold, 2005). Most
rely on inductive plethysmography of chest expansion and have been proven to be
reliable in differentiating between apnea (Lonbe et al., 1999) and show reliable
estimation of volumetric respiratory measures during tasks of everyday life
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(Grossman et al., 2010), and during exercise (Clarenbach et al., 2005). However,
these approaches have yet to be validated for chronic assessment of respiratory
volume; a necessary step prior to integration with a life-sustaining closed-loop
control application.
Another limitation of the work presented here was lack of respiratory pacing of
respiratory muscles other than the diaphragm muscle. The diaphragm muscle
accounts for only 65% of inspiratory force produced during eupnic breathing, with
the other 35% attributed to external intercostal muscles and accessory muscles
(Jarosz et al., 2012). Being able to elicit only 65% of total inspiratory force limits
the range of respiratory maneuvers that may be achievable while on pacing
support. This includes inability to fully elicit ventilatory profiles requiring very high
inspiratory volumes due to elevated PaCO2 values. This limitation was observable
in experimental studies after spinal cord hemisection, where the reduced intrinsic
activation of the ipsilateral respiratory muscles led to difficulties in attaining the
desired tidal volume. Even though with increase in respiratory rate, a reduction in
etCO2 was still possible, albeit at a slower rate. As mentioned in previous chapters
this could be addressed by modifying the rCPG model used such that the change
in ventilation relies more on respiratory rate than on tidal volume.
6.4 Future work
The work presented here aimed to develop and implement a closed-loop control
system for respiratory pacing that was capable of regulating PaCO2 through
modulation and control of respiratory rate and breath volume in a physiological-
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like manner. The eventual goal of the work presented here is to deliver a closedloop respiratory control system that is robust enough and safe enough for chronic
clinical use. Assessing controller performance in computational simulations using
a human model of ventilatory dynamics did further this goal. However, extensive
work is still required to achieve clinical implementation of the control system. This
section will discuss possible future work that may lead to increased robustness,
performance, and functionality of the PG/PS control system. Additionally, proper
validation of this control algorithm will be discussed; especially since the controller
offers a life-sustaining technology, failure of which could lead to death.
All experimental studies performed here controlled ventilation through electrical
stimulation of the diaphragm muscle. However, other techniques such as phrenic
nerve stimulation and spinal cord stimulation are currently implemented clinically
or have been explored pre-clinically (DiMarco, 2005; Hachmann et al., 2017;
Jarosz et al., 2012; Khong et al., 2010; Kowalski et al., 2013; Le Pimpec-Barthes
et al., 2016; Mercier et al., 2017; Onders, 2012). While the design of the PG/PS
controller suggests that performance will not be negatively impacted when
implemented in other stimulation modalities, it is possible that performance may
improve. In the case of phrenic nerve stimulation, there would be no need for
mapping of the diaphragm motor point. This would reduce risk of erroneous
electrode placement and provide a more widespread activation of the diaphragm
with sufficient stimulation than is possible via diaphragmatic stimulation (Onders,
2012). Spinal cord stimulation suggests further benefits in exchange for a riskier
electrode implantation process. If spinal cord stimulation stimulates the premotor
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phrenic pathways, the intrinsic muscle activation dynamics are preserved, avoiding
the issue of reverse recruitment (Hachmann et al., 2017; Kowalski et al., 2013).
This may lead to a more natural diaphragm muscle contraction, finer control of
diaphragm muscle contraction, and increased time before onset of muscle fatigue.
Furthermore, spinal cord stimulation takes advantage of the intrinsic spinal
connectivity between phrenic motor pools and other inspiratory muscles, mainly
the external intercostals. Spinal cord stimulation of the phrenic motor pools has
been shown to cause activation of external intercostal muscles (Dimarco et al.,
1997; DiMarco et al., 2005; DiMarco and Kowalski, 2013). This can thus lead to
further reduction in muscle fatigue as the mechanical work of breathing can be
distributed between the diaphragm and external intercostal muscles, reducing the
workload on the diaphragm.
Other than reducing the respiratory workload of the diaphragm, respiratory pacing
of additional respiratory muscles can lead to other benefits. Addition of intercostal
muscles would lead to an overall increase in elicited inspiratory capacity, allowing
for the production of non-ventilatory behaviors that require high inspiratory
volumes, such as sighing. Meanwhile, addition of expiratory muscle control would
allow for forceful expiration, allowing behaviors such as active expiration and
coughing. Control of external intercostal muscles by applying the same stimulation
pattern given by the PS module that is controlling the diaphragm muscle has
shown some promise in ongoing experiments (not reported). However, control of
expiratory muscles would require an additional PS module that controls expiratory
activity. This expiratory PS would need to be linked to the expiratory neuronal
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population within the PG module through an appropriate expiratory muscle model
in a similar manner as is currently done for the inspiratory PS. Implementation of
these behaviors in the controller could be done by expanding the intrinsic
capabilities of the PG to include additional responses (as for active expiration), or
by including subroutines into the PG module that are activated either as a timed
response (for sighing), or a triggered response (as for coughing).
Pre-clinical validation of the adaptive PG/PS controller in chronic models is also
suggested prior to clinical implementation. Acute studies do not address factors
that may be present in chronic animal studies such as electrode encapsulation,
spinal shock due to injury, respiratory neuroplasticity, and chronic changes in
diaphragm muscle fiber properties. Carrying out chronic studies would allow for
assessment of the controller’s response to these factors and other factors that may
be present but have not been accounted for. Through chronic studies, the
controller would not only be further optimized to ensure robustness, reliability, and
safety but also lead to evaluation of the controller’s long-term effect on muscular
and neural tissue.
Finally, early feasibility clinical trials would need to be performed in order to
transition to extensive clinical trials. Early feasibility clinical trials could possibly be
carried out under clinician supervision within operating rooms during procedures
when maintenance of existing diaphragm pacers is performed. This would not
require an extensive acclimatization period to pacing nor require additional surgical
procedures. The existing leads could either be interfaced with an external
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stimulator controlled by the adaptive controller or the adaptive controller could be
linked with the implanted stimulator. Either way would take advantage of
electrodes already implanted in the diaphragm or on the phrenic nerve, minimizing
risk and cost of the study.
In conclusion, an adaptive closed-loop controller for respiratory pacing was
developed and assessed in acute pre-clinical models. The adaptive controller was
able to respond to changes in PaCO2 to generate a proper ventilatory response
and was able to adapt stimulation pulses delivered to the diaphragm to elicit this
ventilatory response. While extensive work is still required prior to clinical
implementation of the system, the work presented here serves as an important
step towards use of a technology that can allow patients with chronic
hypoventilation to lead a more independent and healthier lifestyle.
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